boyd
cj
clau
sharp
cr
raisi
ar
hosgood
g
smart
l
murdoch
univers
perth
wa
australia
winner
veterinari
emerg
critic
care
foundat
research
grant
introduct
hydroxyethyl
starch
he
associ
acut
kidney
injuri
aki
peopl
limit
evid
dog
present
protocol
feasibl
analysi
ongo
prospect
random
blind
phase
ii
clinic
trial
method
dog
univers
hospit
prescrib
fluid
bolu
clinic
reason
random
receiv
least
mlkg
he
hartmann
solut
mlkg
studi
fluid
fluid
administr
urin
neutrophil
lipocalin
cystatin
c
collect
prior
hour
first
studi
fluid
bolu
serum
creatinin
measur
daili
day
discharg
target
sampl
size
per
group
screen
enrol
target
per
week
respect
popul
characterist
feasibl
outcom
first
week
enrol
report
result
dog
log
screen
per
week
enrol
per
week
reason
exclus
includ
dehydr
transfus
requir
consent
declin
insuffici
time
enrol
predict
hospit
hour
twelv
dog
enrol
administ
intervent
one
taken
home
medic
advic
one
administ
transfus
place
intervent
one
longer
requir
intervent
dog
administ
intervent
median
rang
applefast
score
septic
median
rang
volum
intervent
fluid
mlkg
mlkg
four
major
protocol
violat
relat
volum
intervent
fluid
administ
nine
dog
complet
blood
urin
sampl
time
point
two
dog
develop
aki
hospit
base
veterinari
acut
kidney
injuri
score
one
stage
one
stage
nine
dog
surviv
discharg
die
euthan
due
prognosi
conclus
recruit
rate
lower
project
mainli
due
lower
number
dog
screen
investig
satisfi
enrol
case
repres
popul
clinic
interest
enrol
protocol
violat
highlight
challeng
perform
clinic
intervent
studi
emerg
medicin
allen
tarigo
brainard
barber
levin
georgia
athen
ga
usa
state
univers
ame
ia
usa
introduct
immun
thrombocytopenia
itp
caus
sever
thrombocytopenia
dog
emerg
therapi
includ
administr
vincristin
increas
platelet
number
unknown
newli
releas
platelet
fulli
function
object
studi
evalu
function
immatur
reticul
platelet
releas
follow
singl
intraven
dose
vincristin
healthi
adult
dog
method
ten
healthi
research
dog
receiv
either
singl
iv
inject
mgkg
vincristin
similar
volum
salin
prior
treatment
platelet
express
fibrinogen
bind
antibodi
assess
without
activ
human
gamma
thrombin
hgt
matur
immatur
platelet
distinguish
basi
thiazol
orang
stain
result
vincristin
administr
increas
platelet
concentr
rel
salin
day
day
vs
p
baselin
unstimul
express
greater
reticul
platelet
matur
platelet
p
follow
hgt
stimul
platelet
significantli
differ
express
rel
platelet
except
day
greater
express
p
conclus
reticul
platelet
appear
higher
rest
activ
state
matur
platelet
demonstr
similar
express
fibrinogen
bind
matur
platelet
follow
hgt
stimul
suggest
platelet
function
similarli
matur
platelet
binagia
em
levi
na
koenigshof
michigan
state
univers
east
lans
mi
usa
introduct
sever
studi
peopl
shown
septic
patient
posit
fluid
balanc
day
wors
prognosi
purpos
studi
evalu
daili
cumul
fluid
balanc
canin
septic
periton
patient
method
medic
record
search
dog
diagnosi
septic
periton
patient
exclud
urinari
cathet
place
within
hour
patient
hospit
less
hour
daili
cumul
fluid
balanc
determin
hour
fluid
balanc
calcul
total
fluid
intak
intraven
fluid
blood
product
enter
parenter
nutrit
minu
total
fluid
output
urin
measur
via
urinari
cathet
abdomin
drain
product
nasogastr
tube
aspir
result
patient
met
inclus
criteria
survivor
nonsurvivor
differ
fluid
balanc
hour
survivor
nonsurvivor
patient
posit
fluid
balanc
hour
daili
fluid
balanc
significantli
lower
survivor
day
compar
nonsurvivor
mlkg
mlkg
respect
p
day
daili
fluid
balanc
also
significantli
lower
survivor
compar
nonsurvivor
mlkg
mlkg
respect
p
cumul
fluid
balanc
day
significantli
lower
survivor
compar
nonsurvivor
mlkg
mlkg
respect
p
differ
cumul
fluid
balanc
day
group
length
hospit
survivor
posit
correl
fluid
balanc
day
r
p
cumul
fluid
balanc
day
r
p
conclus
canin
septic
periton
patient
nonsurvivor
significantli
higher
daili
fluid
balanc
day
higher
cumul
balanc
day
futur
studi
need
evalu
effect
posit
fluid
balanc
outcom
dog
septic
periton
bluting
l
zollo
weltman
j
pritti
j
anim
medic
center
new
york
ny
usa
introduct
variou
lactat
variabl
ill
sever
score
system
shown
util
predict
outcom
critic
ill
human
veterinari
patient
aim
determin
whether
lactat
variabl
andor
acut
patient
physiolog
laboratori
evalu
score
applefast
could
discrimin
hospit
survivor
dog
noncardiogen
shock
method
dog
noncardiogen
shock
present
emerg
care
prospect
enrol
primari
outcom
surviv
discharg
secondari
outcom
need
blood
product
administr
applefast
calcul
admiss
venou
lactat
concentr
measur
predetermin
time
point
admiss
lactat
lactat
variabl
lactim
lactat
clearanc
lacarea
applefast
compar
survivor
nonsurvivor
applefast
assess
correl
lactim
lacarea
lactat
clearanc
result
neither
admiss
lactat
applefast
predict
outcom
lactim
shorter
survivor
p
lactat
clearanc
hour
h
p
p
p
greater
survivor
lacarea
time
interv
hour
p
hour
p
hour
p
hour
p
larger
nonsurvivor
total
lacarea
differ
group
applefast
significantli
correl
admiss
lactat
p
lacarea
time
hour
p
lacarea
time
interv
hour
p
applefast
p
predict
need
blood
product
conclus
admiss
venou
blood
lactat
concentr
applefast
fail
discrimin
hospit
survivor
nonsurvivor
popul
serial
lactat
measur
predict
outcom
dog
clinic
evid
shock
addit
applefast
lacarea
hour
predict
need
blood
product
transfus
studi
suggest
serial
biomark
measur
may
use
predict
outcom
critic
ill
patient
compar
individu
measur
cudney
se
wayn
rozanski
ea
cum
school
veterinari
medicin
tuft
univers
north
grafton
usa
introduct
spontan
hemoabdomen
common
emerg
present
dog
major
case
due
splenic
hepat
neoplasia
abdomin
ultrasonographi
au
often
recommend
prior
surgeri
evalu
locat
primari
mass
evid
metastat
diseas
although
evid
accuraci
imag
unknown
goal
studi
evalu
accuraci
au
predict
gross
evid
lesion
either
exploratori
surgeri
necropsi
hypothesi
au
high
specif
low
sensit
identif
lesion
method
dog
present
nontraumat
spontan
hemoabdomen
evalu
abdomin
ultrasound
either
surgic
explor
necropsi
within
hour
present
elig
inclus
dog
euthan
prior
diagnost
treatment
evalu
ultrasound
also
exclud
abil
au
accur
predict
splenic
lesion
liver
mass
liver
nodul
diffus
nodular
metastat
lesion
evalu
result
two
hundr
dog
present
spontan
hemoabdomen
time
frame
evalu
met
inclus
criteria
overal
dog
grossli
detect
lesion
visual
abdomin
ultrasound
base
upon
surgic
necropsi
find
au
sensit
specif
identifi
splenic
mass
n
sensit
specif
liver
mass
n
sensit
specif
identifi
liver
nodul
n
sensit
specif
identifi
diffus
nodular
metastat
diseas
n
conclus
abdomin
ultrasonographi
high
specif
low
sensit
detect
diseas
liver
spleen
diffus
nodular
metastasi
dog
present
nontraumat
spontan
hemoabdomen
util
au
includ
benefit
potenti
limit
consid
prior
perform
test
clinic
set
davidow
montgomeri
mens
employ
seattl
wa
usa
leaf
pet
corner
seattl
wa
usa
veterinari
partner
seattl
wa
usa
introduct
leukoreduct
lr
pack
red
blood
cell
prbc
decreas
incid
nonhemolyt
febril
transfus
reaction
fnhtr
potenti
improv
outcom
peopl
dog
lr
decreas
presenc
inflammatori
mediat
transfus
studi
dog
compar
reaction
rate
lr
prbc
transfus
method
transfus
administ
multispecialti
hospit
track
begin
januari
transfus
event
involv
dog
receiv
prbc
juli
retrospect
review
record
data
patient
donor
unit
transfus
event
subsequ
reaction
hospit
discharg
caus
death
also
record
result
total
transfus
event
identifi
event
exclud
due
lack
data
posttransfus
use
outsid
blood
unit
remain
event
patient
use
lr
prbc
use
nlr
prbc
blood
donat
dog
process
blood
bank
note
patient
transfus
overal
rate
reaction
one
hundr
nonsever
sever
common
reaction
hemolysi
fnhtr
event
higher
rate
mortal
higher
rate
fnhtr
nlr
prbc
event
howev
differ
statist
signific
odd
ratio
estim
effect
lr
odd
death
euthanasia
odd
fnhtr
type
anemia
affect
risk
reaction
older
age
prbc
significantli
increas
odd
hemolysi
sever
multipl
clinic
sign
transfus
reaction
increas
prbc
unit
age
increas
mortal
odd
respiratori
type
reaction
increas
greater
number
previou
transfus
conclus
studi
age
unit
influenti
transfus
reaction
rate
lr
affect
mortal
futur
studi
would
need
conclus
prove
disprov
effect
lr
outcom
fnhtr
de
rosa
sm
drobatz
kj
reinek
el
univers
pennsylvania
philadelphia
pa
usa
introduct
determin
differ
doppler
blood
pressur
sbp
measur
taken
coccyg
arteri
compar
common
digit
branch
radial
arteri
sick
cat
present
emerg
servic
without
abnorm
tissu
perfus
secondari
object
determin
site
differ
sbp
cat
hypotens
normotens
hypertens
method
cat
prospect
enrol
triag
assess
prior
therapeut
intervent
two
three
sbp
measur
taken
site
coccyg
radial
order
site
random
cat
classifi
hypoperfus
least
two
follow
physic
examin
paramet
abnorm
capillari
refil
time
mucou
membran
color
heart
rate
puls
qualiti
rectal
temperatur
cat
classifi
hypertens
sbp
mm
hg
normotens
sbp
mm
hg
hypotens
sbp
mm
hg
base
averag
sbp
obtain
site
result
mean
coccyg
sbp
significantli
greater
mean
radial
sbp
cat
evalu
togeth
n
vs
p
mean
coccyg
sbp
also
significantli
higher
cat
normal
perfus
n
vs
p
hypoperfus
cat
n
vs
p
normotens
cat
n
vs
p
signific
differ
coccyg
sbp
radial
sbp
hypertens
cat
n
vs
p
hypotens
cat
n
vs
p
conclus
coccyg
sbp
significantli
greater
radial
sbp
cat
normal
perfus
hypoperfus
cat
normal
sbp
differ
sbp
site
cat
hypertens
hypotens
although
number
cat
group
small
larger
studi
need
evalu
sbp
cat
abnorm
blood
pressur
well
compar
measur
direct
arteri
pressur
consciou
cat
donaldson
barfield
royal
veterinari
colleg
london
unit
kingdom
introduct
mechan
ventil
mv
routin
perform
dog
cat
support
respiratori
function
sever
hypoxemia
hypercapnia
respiratori
fatigu
unknown
whether
dog
cat
receiv
mv
experi
effect
complic
mv
qualiti
life
affect
method
medic
record
review
use
databas
term
mv
within
medic
histori
discharg
report
januari
februari
case
includ
studi
receiv
mv
intens
care
unit
icu
subsequ
wean
ventil
discharg
hospit
refer
veterinarian
contact
learn
patient
aliv
obtain
relev
clinic
histori
owner
contact
respond
telephon
survey
result
total
record
retriev
initi
search
six
equin
record
exclud
remain
patient
mechan
ventil
icu
sixti
patient
wean
ventil
patient
discharg
hospit
three
exclus
incomplet
contact
detail
medic
unfit
owner
respond
survey
owner
dog
cat
respond
rate
pet
qualiti
life
prior
ill
necessit
ventil
good
excel
perceiv
recoveri
period
rang
day
month
common
respons
week
fourteen
owner
state
pet
qualiti
life
good
better
previous
patient
persist
qualiti
life
concern
n
ventil
neurolog
diseas
four
owner
report
chang
behavior
startl
easili
excess
respons
nois
one
cat
becam
deaf
time
survey
regain
hear
commonli
report
problem
includ
decreas
exercis
toler
n
respond
state
would
ventil
pet
conclus
major
patient
discharg
hospit
follow
mv
similar
qualiti
life
ill
may
influenc
owner
mv
indic
donaldson
cortellini
humm
k
royal
veterinari
colleg
london
unit
kingdom
introduct
atracurium
nondepolar
benzylisoquinolinium
agent
commonli
use
improv
patient
synchroni
mechan
ventil
mv
degrad
atracurium
produc
laudanosin
cumul
associ
central
nervou
system
excit
seizur
peopl
object
studi
investig
seizur
occurr
canin
felin
patient
mv
evalu
atracurium
administr
increas
preval
method
medic
record
veterinari
univers
teach
hospit
review
cat
dog
underw
mv
intens
care
unit
icu
januari
februari
signal
record
seizur
activ
whether
patient
wean
mv
outcom
discharg
hospit
cardiopulmonari
arrest
euthanasia
document
patient
group
administ
atracurium
continu
rate
infus
cri
mv
display
abnorm
neurolog
activ
includ
seizur
wean
mv
statist
analysi
perform
signific
set
p
result
five
hundr
seven
record
retriev
initi
search
cat
dog
mechan
ventil
icu
sixti
patient
wean
mv
sixteen
patient
seizur
activ
document
seizur
activ
prior
mv
remain
patient
seizur
activ
first
time
follow
wean
mv
three
patient
administ
atracurium
cri
six
patient
dog
cat
total
receiv
atracurium
patient
receiv
atracurium
cri
document
seizur
activ
wean
mv
patient
wean
mv
administ
atracurium
cri
like
seizur
p
besid
age
p
signific
differ
atracurium
atracurium
group
age
associ
increas
risk
seizur
overal
p
conclus
appear
associ
seizur
icu
use
atracurium
cri
dog
consid
use
drug
younger
patient
like
receiv
atracurium
institut
ender
musulin
holowaychuk
hale
carolina
state
univers
raleigh
nc
usa
care
vet
consult
calgari
ab
canada
inc
rockvil
md
usa
introduct
hypoalbuminemia
associ
increas
morbid
mortal
critic
ill
peopl
anim
albumin
solut
may
administ
increas
intravascular
volum
colloid
osmot
pressur
hypoalbuminem
anim
aim
studi
evalu
safeti
repeat
administr
novel
lyophil
albumin
csa
product
quantifi
effect
serum
albumin
concentr
colloid
osmot
pressur
cop
healthi
dog
method
six
healthi
beagl
administ
separ
gkg
dose
reconstitut
csa
hemosolut
llc
hour
day
dog
monitor
evid
complic
infus
hour
postinfus
serum
albumin
cop
measur
baselin
hour
infus
complet
blood
count
serum
biochem
analysi
evalu
baselin
day
repeat
measur
anova
use
evalu
collect
albumin
cop
chang
infus
result
dog
toler
csa
infus
evid
acut
hypersensit
reaction
one
dog
vomit
hour
complet
infus
day
occur
immedi
eat
thought
unrel
studi
drug
sinc
dog
display
clinic
abnorm
dog
display
sign
delay
hypersensit
reaction
studi
period
serum
biochemistri
hematolog
profil
remain
within
normal
limit
time
point
colloid
osmot
pressur
increas
mean
mm
hg
hour
rang
mm
hg
p
remain
significantli
higher
baselin
p
hour
p
postinfus
serum
albumin
increas
mean
gdl
hour
rang
gdl
p
remain
significantli
higher
baselin
p
hour
p
postinfus
conclus
dose
csa
effect
increas
serum
albumin
cop
repeat
infus
appear
safe
advers
chang
physic
examin
hematolog
biochem
paramet
fick
hansen
solomon
vigani
carolina
state
univers
raleigh
nc
usa
institut
health
bethesda
md
usa
introduct
although
experiment
endotoxemia
may
affect
serum
sngal
urin
ungal
concentr
neutrophil
lipocalin
util
detect
acut
kidney
injuri
dog
sepsi
unknown
aim
studi
compar
establish
renal
function
marker
scr
symmetr
dimethylarginin
sdma
sngal
ungal
canin
septic
shock
determin
relationship
biomark
renal
histopatholog
method
sixti
beagl
receiv
pulmonari
inocul
aureu
cfukg
dog
sedat
mechan
ventil
treat
septic
shock
via
standard
protocol
death
euthanasia
hour
blood
urin
sampl
analysi
collect
inocul
hour
postinocul
complet
necropsi
perform
nephropathologist
blind
dog
ident
evalu
renal
histopatholog
result
dog
surviv
past
complet
sampl
set
time
necropsi
limit
postmortem
autolysi
fourteen
dog
moder
sever
lesion
identifi
via
renal
histopatholog
four
dog
develop
aki
kdigo
scr
criteria
die
hour
moder
sever
lesion
increas
ungal
fifteen
dog
least
increas
ungal
increas
ungal
pgml
dog
mild
lesion
pgml
dog
sngal
chang
slightli
increas
decreas
sdma
increas
decreas
proport
chang
scr
dog
regardless
renal
histopatholog
score
conclus
aki
identifi
chang
serum
creatinin
first
hour
sepsi
dog
ultim
develop
moder
sever
histopatholog
lesion
ungal
rose
time
independ
chang
sngal
markedli
elev
dog
hour
increas
ungal
may
predict
develop
aki
earlier
chang
scr
appear
secondari
inflammatori
state
sepsi
alon
hall
sharp
stillwat
mn
usa
univers
perth
australia
introduct
traumat
injuri
common
lead
caus
death
dog
larg
databas
provid
opportun
assess
improv
patient
care
develop
test
research
hypothes
canin
trauma
case
present
acvecc
vetcot
veterinari
trauma
center
vtc
septemb
april
report
method
use
data
captur
system
redcap
personnel
vtc
prospect
record
admiss
outcom
data
dog
present
follow
trauma
summari
data
describ
result
total
dog
trauma
case
sequenti
vetcot
trauma
registri
includ
major
present
directli
vtc
penetr
trauma
common
follow
blunt
blunt
penetr
injuri
penetr
trauma
predominantli
caus
bite
common
type
blunt
trauma
struck
vehicl
follow
fall
howev
larg
number
caus
blunt
penetr
trauma
classifi
present
data
includ
anim
trauma
triag
att
score
median
iqr
modifi
glasgow
coma
scale
score
median
iqr
evid
head
injuri
dog
spinal
trauma
surgeri
perform
dog
procedur
perform
emerg
room
oper
room
receiv
blood
product
transfus
dog
surviv
discharg
euthan
die
conclus
data
constitut
largest
epidemiolog
studi
trauma
dog
date
major
dog
sustain
rel
minor
trauma
character
low
att
score
high
rate
surviv
discharg
henao
ln
acciacca
ra
sullivan
l
colorado
state
univers
fort
collin
co
usa
introduct
vitamin
c
ascorb
acid
endogen
antioxid
becom
deplet
critic
ill
exogen
supplement
ascorb
acid
improv
outcom
septic
peopl
canin
parvoviru
cpv
caus
septicemia
dog
may
present
similar
correl
blood
ascorb
acid
level
marker
diseas
method
serum
collect
cpv
dog
n
critic
ill
recoveri
compar
serum
collect
healthi
control
dog
month
age
n
measur
ascorb
acid
concentr
use
mass
spectrometri
correl
ascorb
acid
concentr
clinic
diseas
sever
length
hospit
surviv
also
evalu
result
dog
cpv
concurr
neutropenia
n
significantli
differ
serum
ascorb
acid
concentr
baselin
mean
ci
compar
dog
cpv
without
neutropenia
n
mean
ci
healthi
control
dog
n
mean
ci
p
baselin
serum
ascorb
acid
concentr
associ
clinic
sever
score
p
durat
hospit
p
mortal
p
conclus
serum
ascorb
acid
concentr
significantli
differ
dog
infect
cpv
compar
healthi
control
dog
ascorb
acid
level
associ
presenc
neutropenia
marker
diseas
sever
clinic
util
measur
supplement
vitamin
c
popul
critic
ill
dog
uncertain
would
requir
investig
hoehn
sn
hopper
k
epstein
se
univers
california
davi
davi
ca
usa
introduct
recent
retrospect
studi
report
increas
return
spontan
circul
rosc
follow
implement
recov
cardiopulmonari
resuscit
cpr
guidelin
studi
aim
prospect
describ
cpr
outcom
veterinari
teach
hospit
sinc
implement
recov
guidelin
compar
prior
public
evalu
factor
associ
outcom
report
patient
popul
accord
veterinari
guidelin
method
clinician
complet
form
cpr
event
immedi
follow
conclus
form
creat
base
human
guidelin
report
cpr
event
medic
record
retrospect
review
report
categori
adjust
compli
veterinari
guidelin
necessari
group
rosc
achiev
rosc
compar
use
fisher
exact
u
test
result
one
hundr
dog
cat
cardiopulmonari
arrest
cpa
underw
cpr
prospect
enrol
one
hundr
anim
attain
rosc
aliv
hour
discharg
aliv
dog
cat
rate
rosc
compar
facil
prior
introduct
recov
guidelin
significantli
cat
surviv
discharg
vs
p
respiratori
failur
common
suspect
caus
cpa
dog
cat
higher
rosc
rate
seen
wit
cpa
vs
p
palpabl
puls
cpr
vs
p
presenc
peripher
intraven
cathet
cpa
vs
p
cpa
occur
icu
vs
p
median
iqr
time
administr
epinephrin
versu
minut
p
atropin
versu
minut
p
shorter
well
higher
maxim
end
tidal
read
versu
mm
hg
p
patient
achiev
rosc
conclus
wit
cpa
event
earli
cpr
intervent
associ
increas
rosc
emphas
time
cpa
recognit
initi
cpr
although
incorpor
recov
guidelin
improv
rosc
rate
cat
previous
report
surviv
discharg
may
suggest
systemat
approach
cpr
translat
posit
improv
care
kim
sharp
boyd
twomey
univers
murdoch
australia
laboratori
servic
ascot
australia
introduct
pcr
assay
common
canin
enteropathogen
becom
wide
avail
diagnost
tool
investig
acut
diarrhea
dog
preval
enteropathogen
dog
western
australia
current
unknown
primari
object
studi
describ
compar
fecal
pcr
qpcr
result
dog
present
veterinari
facil
western
australia
method
electron
medic
record
anim
hospit
murdoch
univers
tahmu
search
dog
fecal
qpcr
submit
result
compar
major
region
refer
laboratori
vetpath
laboratori
servic
preval
pathogen
compar
group
use
fisher
exact
test
consid
signific
result
tahmu
cohort
n
clostridium
perfringen
toxin
gene
cp
frequent
detect
enteropathogen
case
follow
campylobact
spp
canin
parvoviru
cpv
salmonella
spp
giardia
vetpath
cohort
n
cp
posit
campylobact
spp
posit
cpv
posit
giardia
posit
salmonella
spp
posit
tahmu
cohort
includ
significantli
case
cpv
p
cp
p
tahmu
cohort
diarrhea
present
complaint
dog
major
dog
record
current
vaccin
dog
treat
inpati
surviv
discharg
dog
seen
dog
receiv
antimicrobi
start
antimicrobi
prior
receipt
qpcr
result
follow
qpcr
result
continu
antimicrobi
therapi
drug
select
unchang
dog
dog
current
vaccin
rang
month
median
durat
time
last
vaccin
present
dog
cpv
fecal
antigen
test
perform
test
neg
contrast
posit
cpv
detect
qpcr
dog
current
vaccin
conclus
preval
cpv
significantli
higher
tahmu
cohort
cp
frequent
detect
popul
dog
potenti
role
identifi
pathogen
diseas
requir
elucid
la
bowen
cm
buckley
gj
univers
florida
gainesvil
fl
usa
introduct
endotheli
glycocalyx
eg
biopolym
interfac
locat
lumin
side
endotheli
cell
disrupt
shed
layer
primari
event
microvascular
dysfunct
damag
eg
increas
capillari
permeabl
protein
alter
gradient
subglycocalyx
colloid
osmot
pressur
plasma
colloid
osmot
pressur
result
number
derang
includ
hypoalbuminemia
edema
microvascular
dysregul
ultim
heterogen
perfus
glycocheck
novel
glycocalyx
measur
softwar
provid
autom
analysi
microvascular
video
record
use
side
stream
video
microscopi
use
peopl
object
studi
evalu
endotheli
glycocalyx
layer
popul
healthi
anesthet
dog
use
technolog
method
fifti
healthi
dog
present
elect
procedur
enrol
handheld
video
microscop
connect
glycocheck
softwar
use
acquir
imag
sublingu
microvasculatur
immedi
follow
anesthet
induct
dog
microvascular
read
acquir
perfus
boundari
region
pbr
marker
endotheli
glycocalyx
barrier
properti
red
blood
cell
access
determin
vessel
mm
base
column
width
anesthet
protocol
monitor
macrovascular
paramet
patient
characterist
compil
analysi
alongsid
microvascular
paramet
result
median
time
induct
imag
acquisit
minut
rang
minut
data
acquisit
accomplish
median
time
minut
per
read
minut
applic
microvascular
camera
easili
perform
minim
train
requir
data
acquisit
mean
perfus
boundari
region
measur
segment
pbr
mm
mm
rang
mm
valu
similar
describ
peopl
none
patient
characterist
macrovascular
variabl
anesthet
protocol
use
signific
correl
microvascular
paramet
conclus
studi
demonstr
indirect
evalu
endotheli
glycocalyx
layer
possibl
dog
result
close
resembl
investig
peopl
reveal
potenti
applic
technolog
clinic
set
lynch
ruterbori
griffith
hanel
stablein
brook
carolina
state
univers
raleigh
nc
usa
veterinari
partner
tampa
fl
usa
univers
ithaca
ny
usa
introduct
rivaroxaban
direct
oral
factor
xa
inhibitor
attract
anticoagul
option
dog
report
oral
bioavail
healthi
dog
may
low
impact
concurr
feed
gastroprotect
administr
pharmacodynam
rivaroxaban
dog
current
unknown
aim
pilot
studi
determin
impact
feed
coadminstr
omeprazol
coadministr
sucralf
anticoagul
effect
rivaroxaban
healthi
dog
method
five
healthi
male
neuter
beagl
use
pilot
studi
four
distinct
stage
investig
involv
administr
mgkg
rivaroxaban
daili
consecut
day
either
food
food
g
oral
sucralf
mgkg
oral
omeprazol
minimum
washout
period
employ
stage
one
day
prior
commenc
studi
stage
dog
sedat
facilit
insert
jugular
sampl
cathet
start
next
day
blood
sampl
obtain
use
techniqu
time
hour
rel
rivaroxaban
administr
measur
activ
riva
use
assess
anticoagul
intens
repeat
measur
mix
statist
model
use
post
hoc
tukey
adjust
evalu
impact
stage
riva
level
result
dog
toler
studi
intervent
without
seriou
advers
effect
rivaroxaban
administr
result
signific
chang
individu
dog
riva
p
peak
riva
occur
hour
follow
administr
vari
among
dog
feed
associ
significantli
higher
riva
p
p
time
point
compar
valu
dog
administ
sucralf
overal
howev
administr
rivaroxaban
food
sucralf
omeprazol
significantli
chang
riva
compar
dog
administ
rivaroxaban
empti
stomach
p
conclus
anticoagul
effect
oral
rivaroxaban
base
measur
rivaroxaban
specif
activ
unaffect
concurr
feed
sucralf
omeprazol
administr
healthi
dog
studi
relev
critic
ill
dog
sever
therapeut
intervent
may
provid
concurr
lynch
ruterbori
griffith
hanel
stablein
brook
carolina
state
univers
raleigh
nc
usa
veterinari
partner
tampa
fl
usa
univers
ithaca
ny
usa
introduct
rivaroxaban
increasingli
popular
anticoagul
option
dog
therapeut
monitor
advis
dog
gaug
anticoagul
intens
activ
riva
gold
standard
test
typic
avail
test
assess
anticoagul
effect
rivaroxaban
therefor
problemat
littl
inform
regard
role
coagul
test
rivaroxaban
monitor
aim
studi
assess
correl
riva
prothrombin
time
pt
activ
partial
thromboplastin
time
aptt
thromboelastographi
teg
variabl
thrombin
gener
variabl
method
blood
sampl
collect
healthi
male
neuter
beagl
enrol
rivaroxaban
pharmacodynam
studi
briefli
specif
stage
investig
dog
administ
mgkg
rivaroxaban
daili
consecut
day
either
food
food
g
oral
sucralf
mgkg
oral
omeprazol
minimum
washout
period
stage
blood
sampl
obtain
use
techniqu
jugular
sampl
cathet
time
point
correspond
hour
rivaroxaban
administr
time
point
rapidteg
recalcifi
teg
kaolintissu
factor
activ
perform
harvest
citrat
plasma
later
batch
analysi
riva
pt
aptt
thrombin
gener
pearson
correl
riva
level
pt
aptt
rapidteg
r
rapidteg
rapidteg
g
thrombin
gener
variabl
lag
time
peak
thrombin
endogen
thrombin
potenti
etp
determin
result
total
separ
blood
sampl
avail
analysi
prothrombin
time
strong
posit
correl
riva
r
p
follow
thrombin
gener
lag
time
r
p
aptt
p
rapidteg
variabl
poor
correl
riva
r
r
p
r
p
g
r
p
remain
thrombin
gener
variabl
fair
neg
correl
riva
peak
thrombin
r
p
etp
r
p
conclus
prothrombin
time
correl
best
rivaroxaban
specif
activ
may
prove
conveni
second
line
monitor
option
dog
receiv
rivaroxaban
thromboelastographi
perform
strong
activ
correl
poorli
activ
martini
pm
gogg
r
cornel
univers
ithaca
ny
usa
introduct
accumul
periton
effus
common
dog
rapid
differenti
type
effus
present
import
earli
institut
appropri
diagnost
therapeut
intervent
variou
biomark
evalu
previou
studi
simultan
measur
multipl
biomark
blood
effus
determin
discrimin
underli
caus
studi
aim
compar
blood
effus
concentr
novel
biomark
dog
septic
periton
sp
nonsept
periton
nsp
caus
periton
effus
ope
method
eighteen
dog
sp
control
system
inflamm
nsp
control
without
system
inflamm
ope
prospect
enrol
blood
effus
obtain
present
concentr
dna
cfdna
glucos
high
mobil
group
inflammatori
cytokin
lactat
natriuret
peptid
neutrophil
gelatinas
associ
lipocalin
ngal
nucleosom
procalcitonin
pct
measur
within
group
biomark
concentr
compar
wilcoxon
test
group
biomark
concentr
blood
effus
compar
dunn
post
hoc
test
multipl
comparison
gradient
also
compar
group
adjust
multipl
comparison
bonferroni
correct
result
dog
sp
multipl
biomark
includ
cfdna
glucos
ngal
nucleosom
inflammatori
cytokin
significantli
differ
blood
effus
dog
nsp
ope
concentr
significantli
differ
blood
effus
effus
concentr
lactat
significantli
differ
dog
sp
compar
dog
nsp
biomark
except
cfdna
lactat
pct
significantli
differ
dog
sp
ope
mani
biomark
gradient
also
significantli
differ
dog
sp
compar
ope
includ
glucos
lactat
nucleosom
cytokin
conclus
studi
suggest
dog
sp
particularli
concentr
multipl
biomark
differ
blood
versu
effus
addit
measur
novel
biomark
blood
effus
use
aid
differenti
effus
distinct
pathophysiolog
origin
martini
pm
gogg
r
cornel
univers
ithaca
ny
usa
introduct
septic
periton
sp
defin
presenc
bacteria
within
abdomin
caviti
common
dog
associ
high
mortal
earli
recognit
aggress
manag
essenti
maxim
surviv
biomark
diagnosi
sp
evalu
dog
date
studi
aim
evalu
util
novel
biomark
diagnosi
sp
dog
method
eighteen
dog
sp
control
evid
system
inflamm
nonsept
abdomin
effus
nsp
prospect
enrol
blood
effus
obtain
present
concentr
dna
cfdna
glucos
high
mobil
group
inflammatori
cytokin
lactat
natriuret
peptid
neutrophil
gelatinas
associ
lipocalin
ngal
nucleosom
procalcitonin
pct
measur
use
commerci
reagent
assay
gradient
compar
dog
sp
nsp
u
test
adjust
multipl
comparison
bonferroni
correct
receiv
oper
characterist
roc
curv
analysi
calcul
area
curv
auroc
use
determin
discrimin
gradient
identif
sp
result
compar
dog
nsp
dog
sp
significantli
greater
gradient
motif
chemokin
ligand
lactat
p
significantli
smaller
gradient
glucos
p
roc
curv
analysi
indic
biomark
discrimin
differenti
sp
nsp
calcul
auroc
indic
least
discrimin
auroc
p
auroc
p
glucos
auroc
p
lactat
auroc
p
auroc
p
conclus
studi
suggest
gradient
glucos
lactat
discrimin
differenti
sp
nsp
dog
three
biomark
inflammatori
cytokin
requir
complex
laboratori
analys
other
measur
point
care
therefor
studi
support
use
gradient
glucos
lactat
differenti
sp
nsp
dog
mauro
kd
nesser
thawley
vj
otto
cm
univers
pennsylvania
philadelphia
pa
usa
introduct
septic
periton
associ
signific
morbid
mortal
potenti
therapeut
agent
treatment
sepsi
desulf
heparin
odsh
reduc
histon
platelet
factor
murin
sepsi
model
clinic
trial
evalu
safeti
effect
odsh
dog
septic
periton
potenti
use
odsh
novel
therapeut
septic
periton
investig
method
prospect
clinic
trial
dog
spontan
septic
periton
odsh
treatment
initi
follow
surgic
intervent
dose
escal
base
aptt
prior
odsh
dosag
platelet
count
white
blood
cell
count
dna
collect
time
odsh
dosag
addit
applefast
appleful
score
admiss
sourc
septic
periton
requir
vasopressor
administr
blood
product
surviv
discharg
record
result
six
dog
femal
neter
femal
intact
male
neuter
enrol
mean
applefast
appleful
score
admiss
respect
gastrointestin
dog
hepatobiliari
splenic
dog
urogenit
dog
sourc
sepsi
identifi
two
dog
receiv
vasopressor
postop
period
four
dog
receiv
dosag
odsh
dog
receiv
dosag
odsh
intraven
dog
requir
dose
dog
evid
bleed
mean
dosag
odsh
mgkg
four
dog
surviv
discharg
conclus
advers
effect
odsh
seen
dog
septic
periton
random
control
trial
necessari
evalu
odsh
novel
therapeut
treatment
septic
periton
mcmanamey
ak
lynch
keen
bw
north
carolina
state
univers
raleigh
nc
usa
introduct
hemangiosarcoma
idiopath
effus
consid
common
caus
pce
dog
recogn
demograph
predisposit
eg
older
larg
breed
dog
etiolog
pce
less
typic
breed
less
well
defin
studi
perform
character
etiolog
pce
larg
cohort
dog
underw
emerg
pericardiocentesi
method
electron
record
dog
underw
emerg
pericardiocentesi
abstract
age
bodi
weight
breed
etiolog
pce
result
record
dog
analyz
median
age
year
rang
median
weight
kg
rang
hemangiosarcoma
right
atrial
mass
compat
hemangiosarcoma
common
diagnosi
present
dog
hemangiosarcoma
less
like
diagnosi
dog
kg
vs
p
left
atrial
ruptur
vs
p
suppur
pericard
vs
p
like
dog
weigh
kg
dog
weigh
kg
like
open
diagnosi
vs
p
carcinoma
vs
p
compar
dog
weigh
kg
dog
without
hemangiosarcoma
year
age
significantli
like
mesothelioma
vs
p
suppur
vs
p
idiopath
pericardi
effus
vs
p
dog
year
brachycephal
breed
less
like
hemangiosarcoma
vs
p
left
atrial
ruptur
vs
p
caus
pce
like
chemodectoma
vs
p
compar
nonbrachycephal
breed
conclus
hemangiosarcoma
right
atrial
mass
thought
hemangiosarcoma
common
caus
pce
dog
requir
emerg
pericardiocentesi
epoch
howev
altern
diagnos
often
found
younger
smaller
brachycephal
breed
murphi
evan
tansey
wieb
sloan
patlogar
northcutt
nakamura
specialist
emerg
servic
upland
ca
usa
veterinari
care
center
lawndal
ca
usa
specialti
center
new
castl
de
usa
specialti
emerg
center
thousand
oak
ca
usa
introduct
rivaroxaban
oral
administ
factor
xa
inhibitor
shown
effect
safe
prevent
venou
thromboembol
peopl
reduc
risk
bleed
complic
compar
warfarin
due
predict
pharmacokinet
pharmacodynam
routin
laboratori
monitor
requir
peopl
aim
studi
determin
rivaroxaban
administ
mgkg
oral
daili
group
healthi
dog
produc
signific
chang
hemostat
paramet
method
eleven
dog
baselin
complet
blood
count
fibrinogen
platelet
count
serum
chemistri
profil
prothrombin
time
activ
partial
thromboplastin
time
thromboelastographi
perform
dog
administ
approxim
mgkg
rivaroxaban
oral
daili
week
blood
work
hemostat
paramet
result
one
dog
exclud
due
identif
macrocyt
thrombocytopenia
pretreat
blood
work
remain
enrol
dog
receiv
median
dose
mgkg
rang
mgkg
rivaroxaban
daili
signific
increas
platelet
count
fibrinogen
signific
chang
hemostat
paramet
conclus
primari
find
studi
rivaroxaban
administ
mgkg
oral
daili
week
fail
produc
signific
chang
hemostat
paramet
appar
healthi
dog
signific
increas
fibrinogen
level
platelet
count
dog
receiv
rivaroxaban
increas
associ
inflamm
may
indic
rivaroxaban
could
potenti
proinflammatori
potenti
import
find
rivaroxaban
typic
use
condit
inflamm
concurr
present
hemolyt
anemia
effect
rivaroxaban
inflammatori
biomark
dog
may
requir
investig
osborn
lg
jm
epstein
se
hopper
k
univers
california
davi
davi
ca
usa
introduct
acidemia
common
dog
addison
diseas
gener
attribut
impair
renal
hydrogen
ion
excret
lactic
acidosi
semiquantit
assess
character
veterinari
literatur
character
influenc
affect
fluid
choic
primari
object
retrospect
studi
describ
semiquantit
statu
dog
natur
occur
addison
diseas
compar
statu
determin
tradit
analysi
method
electron
medic
record
databas
univers
teach
hospit
search
dog
addison
diseas
dog
includ
addison
diseas
stimul
serum
cortisol
concentr
panel
serum
biochemistri
panel
drawn
within
hour
present
patient
exclud
na
k
ratio
patient
receiv
corticosteroid
medic
within
preced
month
tradit
semiquantit
analys
perform
describ
result
case
met
studi
criteria
tradit
analysi
identifi
normal
statu
dog
simpl
respiratori
abnorm
dog
simpl
metabol
acidosi
dog
mix
disord
common
occur
patient
semiquantit
approach
identifi
metabol
abnorm
case
dog
acidifi
process
acidifi
alkalin
process
acidosi
attribut
excess
free
water
present
dog
acidifi
phosphat
effect
present
hyperlactatemia
contribut
acidosi
patient
median
lactat
mmoll
rang
mmoll
common
alkalin
effect
hypoalbuminemia
conclus
studi
demonstr
dog
untreat
addison
diseas
complex
derang
semiquantit
approach
analysi
provid
greater
insight
underli
mechan
metabol
abnorm
patient
particularli
sinc
lactic
acidosi
appear
minor
influenc
case
result
suggest
dog
addison
diseas
may
benefit
fluid
resuscit
use
balanc
electrolyt
solut
contain
buffer
lower
sodium
chlorid
concentr
nacl
scotti
km
levi
na
koenigshof
michigan
state
univers
east
lans
mi
usa
introduct
felin
appl
acut
patient
physiolog
laboratori
evalu
score
develop
tool
stratifi
ill
sever
cat
admit
intens
care
unit
appleful
score
util
paramet
maximum
score
applefast
score
util
paramet
maximum
score
higher
score
associ
wors
prognosi
system
develop
valid
institut
howev
prospect
evalu
sinc
initi
public
goal
studi
prospect
evalu
util
felin
appl
score
system
predict
outcom
cat
admit
novel
icu
method
cat
admit
icu
time
period
januari
prospect
enrol
follow
owner
consent
felin
appleful
applefast
score
calcul
within
hour
admiss
result
one
hundr
cat
includ
studi
survivor
nonsurvivor
euthanasia
natur
death
median
age
year
iqr
year
median
weight
kg
kg
median
length
hospit
loh
day
iqr
appleful
score
calcul
cat
significantli
lower
survivor
nonsurvivor
mean
sd
sd
respect
p
auroc
area
receiv
oper
characterist
curv
appleful
score
improv
exclud
nonsurvivor
euthan
applefast
score
calcul
cat
significantli
lower
survivor
nonsurvivor
mean
sd
sd
respect
p
auroc
applefast
score
improv
exclud
euthan
nonsurvivor
appleful
score
posit
correl
loh
cat
surviv
discharg
p
r
though
applefast
score
p
conclus
appleful
score
good
prognost
indic
popul
hospit
cat
euthan
cat
exclud
reliabl
score
system
predict
outcom
veterinari
medicin
complic
option
euthanasia
sharp
hall
univers
perth
australia
stillwat
mn
usa
introduct
traumat
injuri
common
lead
caus
death
cat
larg
databas
provid
opportun
assess
improv
patient
care
develop
test
research
hypothes
felin
trauma
case
present
acvecc
vetcot
veterinari
trauma
center
vtc
septemb
april
report
method
use
data
captur
system
redcap
personnel
vtc
prospect
record
admiss
outcom
data
cat
present
follow
trauma
summari
data
describ
result
total
cat
trauma
case
vetcot
trauma
registri
includ
major
present
directli
vtc
blunt
trauma
common
follow
penetr
blunt
penetr
injuri
common
type
blunt
trauma
motor
vehicl
accid
follow
fall
penetr
trauma
predominantli
caus
bite
howev
larg
number
caus
trauma
classifi
present
data
includ
anim
trauma
triag
att
score
median
rang
modifi
glasgow
coma
scale
score
median
rang
cat
evid
head
injuri
spinal
trauma
surgeri
perform
cat
procedur
perform
emerg
room
oper
room
receiv
blood
product
transfus
cat
surviv
discharg
euthan
die
conclus
data
constitut
largest
epidemiolog
studi
trauma
cat
date
major
cat
sustain
rel
minor
trauma
character
low
att
score
high
rate
surviv
discharg
stastni
koenigshof
levi
na
michigan
state
univers
east
lans
mi
usa
introduct
recent
focu
human
veterinari
medicin
earli
detect
risk
stratif
septic
patient
sepsi
definit
recommend
use
quick
sequenti
organ
failur
assess
qsofa
score
rapidli
identifi
septic
patient
greater
risk
poor
outcom
via
assess
three
clinic
criteria
systol
blood
pressur
respiratori
rate
mental
statu
similarli
high
ratio
nlr
identifi
independ
associ
unfavor
prognosi
human
septic
patient
nlr
qsofa
score
evalu
dog
purpos
studi
assess
prognost
util
system
inflammatori
respons
syndrom
sir
criteria
nlr
qsofa
score
mortal
among
dog
septic
periton
method
medic
record
dog
diagnos
septic
periton
review
signal
length
hospit
loh
admiss
vital
sign
doppler
blood
pressur
glucos
lactat
vasopressor
use
differenti
wbc
count
record
sir
criteria
qsofa
score
nlr
obtain
result
one
hundr
patient
met
inclus
criteria
overal
mortal
patient
die
euthan
like
qsofa
p
rel
risk
rr
odd
ratio
qsofa
neg
associ
blood
pressur
p
r
patient
qsofa
like
receiv
vasopressor
qsofa
p
rr
qsofa
score
lactat
posit
correl
p
r
differ
nlr
survivor
nonsurvivor
qsofa
score
nlr
correl
patient
met
sir
criteria
differ
frequenc
sir
diagnosi
survivor
nonsurvivor
conclus
qsofa
associ
higher
risk
morbid
mortal
within
studi
popul
suggest
qsofa
may
util
identifi
patient
greater
risk
vasopressor
requir
poor
outcom
howev
prospect
studi
would
necessari
valid
assess
tool
prognost
util
identifi
nlr
outcom
popul
howev
evalu
larger
popul
need
wolf
jm
stefanovski
silverstein
dc
univers
pennsylvania
philadelphia
pa
usa
introduct
long
postul
urem
patient
alter
lactat
concentr
yet
studi
human
veterinari
medicin
demonstr
clinic
previou
studi
suggest
two
main
etiolog
alter
lactat
concentr
uremia
decreas
product
via
urem
mitochondri
dysfunct
increas
excret
via
proxim
convolut
tubul
kidney
studi
sought
demonstr
alter
lactat
concentr
dog
cat
present
emerg
depart
univers
hospit
hypothes
azotem
hypotens
patient
would
significantli
lower
lactat
nonazotem
hypotens
dog
cat
present
emerg
depart
method
electron
medic
record
databas
search
dog
cat
present
emerg
depart
sever
azotemia
creatinin
mgdl
hypotens
doppler
blood
pressur
mm
hg
lactat
measur
within
hour
one
anoth
nonazotem
normotens
patient
nonazotem
hypotens
patient
azotem
normotens
patient
present
emerg
servic
use
control
popul
patient
exclud
analysi
known
caus
type
b
lactic
acidosi
hypertens
doppler
blood
pressur
mm
hg
incomplet
medic
record
result
dog
cat
hypotens
sever
azotemia
lower
lactat
dog
cat
hypotens
without
azotemia
p
respect
median
lactat
concentr
hypotens
dog
mmoll
cat
mmoll
sever
azotemia
within
normal
limit
conclus
hypotens
anim
sever
azotemia
significantli
decreas
lactat
concentr
compar
hypotens
nonazotem
anim
lactat
concentr
often
within
normal
limit
may
due
either
decreas
mitochondri
product
lactat
increas
excret
lactat
lactat
concentr
use
cautious
make
therapeut
decis
patient
popul
research
need
determin
mechan
respons
signific
abnorm
blood
pressur
lactat
measur
azotem
hypotens
anim
whether
differ
lactat
concentr
exist
acut
chronic
azotem
patient
less
sever
azotemia
wong
ek
koenig
burgess
ba
brainard
bm
green
ce
hurley
dj
univers
georgia
athen
ga
usa
introduct
comput
keyboard
contamin
contribut
infect
hai
studi
shown
daili
clean
result
sustain
reduct
keyboard
contamin
studi
goal
determin
efficaci
three
commonli
use
disinfect
wipe
reduc
bacteri
contamin
keyboard
veterinari
teach
hospit
hypothes
would
differ
agent
method
thirti
keyboard
random
dirti
clean
halv
cultur
obtain
dirti
halv
clean
halv
disinfect
randomli
assign
wipe
ahp
quaternari
qac
allow
dri
cultur
cultur
acquir
steril
premoisten
spong
agit
steril
broth
wrung
broth
plate
onto
tryptic
soy
blood
agar
plate
incub
unit
cfu
enumer
hour
incub
percent
cfu
reduct
dirti
clean
side
calcul
result
unit
reduct
hour
incub
alcohol
confid
interv
ci
qac
ci
ahp
ci
hour
incub
cfu
reduct
alcohol
ci
qac
ci
ahp
ci
signific
differ
percent
reduct
cfu
follow
clean
treatment
group
conclus
three
clean
product
equal
efficaci
reduc
bacteri
keyboard
contamin
studi
requir
assess
routin
keyboard
decontamin
decreas
incid
hai
yankin
carver
koenigshof
florida
gainesvil
fl
usa
state
univers
east
lans
mi
usa
introduct
acetylsalicyl
acid
aspirin
clopidogrel
plavix
commonli
use
dog
prevent
blood
clot
howev
clinic
use
revers
agent
medic
peopl
singl
inject
desmopressin
acet
ddavp
vasopressin
analog
mediat
releas
von
willebrand
factor
endothelium
store
shown
improv
platelet
function
revers
antiplatelet
effect
aspirin
clopidogrel
lead
reduc
periop
bleed
human
patient
drug
aim
studi
evalu
effect
ddavp
platelet
aggreg
healthi
dog
receiv
aspirin
clopidogrel
method
random
crossov
studi
multipl
function
analysi
mpa
perform
whole
heparin
blood
healthi
dog
dog
random
receiv
mgkgd
aspirin
clopidogrel
day
mpa
perform
prior
minut
iv
ddavp
inject
dog
antiplatelet
therapi
washout
period
group
receiv
drug
aspirin
clopidogrel
day
mpa
repeat
baselin
day
ddavp
administr
total
analys
perform
everi
blood
sampl
use
adenosin
diphosph
adp
collagen
col
thrombin
trap
arachidon
acid
aspi
agonist
result
platelet
aggreg
significantli
decreas
administr
clopidogrel
compar
baselin
valu
use
adp
p
aspi
p
trap
p
agonist
signific
differ
platelet
aggreg
administr
aspirin
use
agonist
administr
ddavp
result
signific
increas
platelet
aggreg
clopidogrel
administr
conclus
clopidogrel
result
signific
decreas
platelet
function
healthi
dog
given
dose
mgkgd
day
administr
ddavp
effect
platelet
aggreg
healthi
dog
clopidogrel
therapi
inhibit
platelet
aggreg
note
dog
receiv
aspirin
mgkgdose
period
time
conclus
made
regard
ddavp
effect
aspirin
administr
cole
lp
dawson
c
jepson
r
humm
k
royal
veterinari
colleg
london
unit
kingdom
introduct
system
hypertens
sh
recogn
consequ
acut
kidney
injuri
aki
peopl
describ
felin
canin
aki
retrospect
studi
relationship
sh
aki
sever
assess
cat
dog
literatur
preval
target
organ
damag
either
speci
aim
prospect
studi
describ
preval
sh
associ
hypertens
retinopathi
canin
aki
patient
investig
relationship
sh
sever
aki
method
dog
present
veterinari
univers
referr
hospit
aki
prospect
recruit
juli
march
patient
exclud
diseas
associ
sh
includ
chronic
kidney
diseas
prior
treatment
drug
systol
blood
pressur
sbp
urin
output
uop
evid
fluid
overload
assess
daili
iri
intern
renal
interest
societi
grade
aki
arriv
fundic
examin
find
urin
proteincreatinin
ratio
length
hospit
surviv
discharg
record
system
hypertens
defin
sbp
mm
hg
preval
sh
calcul
relationship
sh
record
factor
examin
use
nonparametr
statist
test
result
dog
elig
inclus
preval
sh
admiss
sever
mm
hg
case
preval
sh
increas
hospit
sever
case
note
dog
evid
hypertens
retinopathi
signific
proteinuria
case
includ
consid
fluid
overload
admiss
develop
fluid
overload
hospit
associ
sh
iri
aki
grade
creatinin
present
oligoanuria
surviv
discharg
length
hospit
proteinuria
dog
fluid
overload
present
like
hypertens
admiss
p
conclus
although
sh
common
dog
aki
target
organ
damag
less
common
system
hypertens
appear
associ
sever
injuri
may
associ
fluid
overload
endo
kawas
miyasho
sano
yamashita
nighttim
anim
hospit
sapporo
japan
gakuen
univers
ebetsu
japan
introduct
tail
attract
site
measur
puls
oximetri
stabl
perfus
evalu
accuraci
puls
oximetri
measur
tail
neonat
puls
oximetri
adhes
sensor
anesthet
dog
hypoxemia
hyperoxemia
method
studi
approv
anim
care
use
committe
rakuno
gakuen
univers
six
beagl
dog
age
year
bodi
weight
kg
includ
studi
use
two
type
puls
oximetri
sensor
ear
sensor
attach
tongu
neonat
adhes
sensor
attach
tail
dog
sensor
connect
masimo
puls
oximet
measur
anesthesia
induc
maintain
sevofluran
intub
arteri
oxygen
satur
record
simultan
compar
puls
oximet
read
oxygen
fraction
inspir
ga
stepwis
reduc
blend
nitrou
oxid
increas
data
analysi
includ
plot
linear
regress
analysi
result
arteri
blood
sampl
pair
obtain
tail
rang
tongu
rang
rang
mean
bia
tail
tongu
p
correspond
precis
valu
coeffici
determin
tail
tongu
p
respect
limit
agreement
tail
tongu
conclus
tail
puls
oximetri
measur
feasibl
demonstr
accur
valu
oxygen
satur
hyperoxemia
hypoxemia
anesthet
dog
neonat
puls
oximetri
adhes
sensor
use
tool
puls
oximetri
dog
tail
gaudett
smart
hugh
sharp
bailey
dandrieux
santo
woodward
boller
melbourn
werribe
australia
univers
murdoch
australia
introduct
endotheli
dysfunct
play
import
role
pathophysiolog
sepsi
may
emerg
novel
therapeut
target
studi
dog
investig
biomark
endotheli
activ
natur
occur
sepsi
lack
herein
investig
chang
marker
endotheli
activ
dog
sever
sepsi
compar
healthi
control
aim
determin
associ
endotheli
marker
concentr
inflammatori
mediat
ill
sever
surviv
discharg
method
eighteen
dog
sever
sepsi
prospect
enrol
two
academ
referr
hospit
healthi
dog
serv
control
group
c
venou
blood
sampl
studi
dog
collect
time
diagnosi
sever
sepsi
plasma
store
analysi
marker
differ
aspect
endotheli
function
quantifi
duplic
canin
elisa
includ
vascular
endotheli
growth
factor
vegf
hyaluronan
ha
plasminogen
activ
von
willebrand
factor
vwf
plasma
concentr
inflammatori
marker
protein
crp
determin
canin
elisa
wilcoxon
test
use
test
differ
group
spearman
rho
determin
associ
variabl
set
result
anim
group
die
due
euthanasia
due
cardiopulmonari
arrest
median
concentr
significantli
higher
vegf
rang
pgml
c
pgml
ha
ngml
c
pgml
ngml
c
ngml
pgml
c
pgml
pgml
c
pgml
c
pgml
pgml
c
pgml
crp
pgml
c
pgml
vwf
c
ngml
multipl
strong
correl
found
endotheli
inflammatori
marker
marker
sever
ill
surviv
discharg
conclus
endotheli
activ
occur
dog
sever
sepsi
similar
result
found
peopl
sepsi
accordingli
vegf
ha
may
potenti
biomark
endotheli
activ
septic
dog
hedg
km
odunayo
smith
r
okafor
cc
univers
tennesse
knoxvil
tn
usa
introduct
intraven
cathet
ivc
use
commonli
manag
critic
ill
anim
institut
use
ivc
remov
institut
routin
replac
ivc
hour
use
goal
studi
evalu
averag
durat
peripher
catheter
small
anim
intens
care
unit
well
common
reason
peripher
cathet
pc
remov
popul
method
dog
cat
admit
small
anim
intens
care
unit
icu
univers
tennesse
june
august
peripher
cathet
place
icu
enrol
studi
site
pc
placement
durat
pc
patient
reason
pc
remov
record
result
patient
enrol
studi
dog
cat
two
hundr
pc
place
cephal
vein
one
hundr
pc
remov
due
patient
discharg
hospit
pc
remov
due
euthanasia
pc
remov
due
pc
occlus
pc
remov
due
phlebiti
mean
durat
catheter
patient
min
rang
min
h
min
patient
cathet
patent
greater
hour
conclus
pc
place
cephal
vein
remov
patient
readi
discharg
occlus
cathet
common
reason
pc
replac
hospit
patient
phlebiti
uncommon
caus
popul
icu
patient
addit
inform
studi
show
pc
may
need
routin
replac
hour
use
kennedi
cr
gladden
j
rozanski
ea
cum
school
veterinari
medicin
tuft
univers
north
grafton
usa
introduct
intraoss
io
cathet
use
place
intraven
cathet
critic
ill
rabbit
data
ideal
cathet
placement
site
primari
goal
studi
determin
io
cathet
place
greater
success
tibia
femur
humeru
rabbit
secondari
goal
compar
commonli
use
clinic
criteria
success
io
catheter
fluoroscop
confirm
success
method
particip
underw
train
session
io
cathet
placement
techniqu
eight
rabbit
cadav
use
particip
attempt
time
cathet
placement
site
tibia
femur
humeru
clinic
success
cs
defin
placement
hypoderm
needl
minut
concurr
abil
manipul
leg
via
cathet
infus
ml
salin
appar
absenc
postinfus
subcutan
fluid
accumul
fluoroscop
success
fs
confirm
infus
iohexol
identifi
intramedullari
flow
via
fluoroscopi
fisher
exact
test
use
compar
fs
rate
site
cathet
placement
p
result
twelv
particip
vari
clinic
experi
recruit
fourteen
cathet
attempt
site
total
attempt
overal
cs
document
case
fs
confirm
p
total
attempt
site
tibial
cathet
humer
femor
fluoroscop
success
p
median
time
fs
placement
shortest
tibia
second
rang
second
follow
humeru
second
rang
second
placement
time
longest
femur
second
rang
second
conclus
rate
success
io
cathet
placement
rabbit
cadav
highest
tibia
follow
humeru
femur
median
placement
time
also
shortest
tibia
clinic
success
criteria
overestim
true
intramedullari
placement
cathet
confirm
via
fluoroscopi
kulhavi
lisciandro
kong
veterinari
ultrasound
hong
kong
hong
kong
countri
veterinari
specialist
spicewood
tx
usa
introduct
pulmonari
edema
spars
report
dog
moder
sever
pulmonari
hypertens
ph
mani
clinician
unawar
ph
complic
accur
diagnosi
import
pulmonari
edema
sever
refractori
loop
diuret
studi
aim
evalu
use
lung
ultrasound
protocol
vetblu
document
pulmonari
edema
lung
patholog
dog
moder
sever
ph
absenc
left
atrial
enlarg
method
prospect
case
seri
privat
own
dog
refer
echocardiographi
mobil
ultrasound
practic
hong
kong
period
patient
systol
pulmonari
arteri
pressur
pap
mm
hg
stage
less
mitral
valv
diseas
includ
studi
presenc
one
one
view
consid
posit
pulmonari
edema
addit
find
describ
use
publish
visual
system
lung
ultrasound
sign
shred
tissu
wedg
nodul
sign
result
approxim
complet
echocardiogram
perform
enrol
period
dog
diagnos
ph
pap
mm
hg
advanc
stage
mitral
valv
diseas
meet
inclus
criteria
complet
studi
review
dog
multipl
view
posit
averag
rang
patient
treat
loop
diuret
cardiogen
edema
initi
present
averag
age
year
rang
averag
la
ao
ratio
rang
averag
systol
pulmonari
arteri
pressur
pap
mm
hg
rang
mm
hg
concurr
respiratori
diseas
identifi
patient
brachycephal
syndrom
singl
dog
lung
mass
conclus
imag
protocol
use
prove
use
combin
echocardiographi
rapid
tool
screen
evid
pulmonari
edema
well
screen
underli
lung
patholog
dog
pulmonari
edema
may
misdiagnos
congest
heart
failur
treat
inappropri
loop
diuret
rather
sildenafil
effect
phosphodiesteras
inhibitor
lehmann
hindrick
hassdenteufel
moritz
bauer
anim
clinic
germani
patholog
germani
introduct
aim
studi
evalu
qualiti
blood
product
produc
centrifug
c
compar
novel
graviti
driven
hollow
fiber
separ
system
hf
method
februari
june
healthi
dog
n
blood
donat
program
includ
alloc
group
c
centrifug
n
hf
system
n
dog
includ
donat
blood
volum
ml
without
sedat
later
recumb
jugular
vein
moder
sever
lipemia
present
donat
sampl
asept
drawn
differ
locat
separ
system
donor
whole
blood
bag
wb
whole
blood
bag
sampl
store
room
temperatur
durat
separ
process
wblate
plasma
bag
p
red
blood
cell
bag
prbc
compar
measur
cell
content
biochem
paramet
eg
total
solid
albumin
electrolyt
run
wb
p
prbc
coagul
time
ptaptt
fibrinogen
concentr
factor
activ
factor
v
factor
viii
antithrombin
von
willebrand
factor
run
sampl
wb
p
wblate
result
separ
hf
result
signific
p
prolong
pt
hf
median
rang
c
rang
aptt
hf
median
rang
c
rang
p
p
separ
fibrinogen
significantli
lower
p
hf
gl
rang
compar
c
gl
rang
addit
signific
lower
concentr
total
solid
albumin
hf
detect
comparison
c
leukodeplet
result
group
signific
decreas
fviii
activ
hf
median
rang
c
median
rang
plasma
storag
wblate
room
temperatur
effect
coagul
time
factor
activ
compar
hf
system
signific
higher
hematocrit
hemoglobin
rbc
count
red
blood
cell
concentr
detect
c
conclus
blood
product
qualiti
neg
affect
use
system
especi
plasma
qualiti
case
absenc
centrifug
system
provid
altern
whole
blood
separ
lisciandro
fosgat
countri
veterinari
specialist
spicewood
tx
usa
pretoria
onderstepoort
south
africa
introduct
lung
ultrasound
lu
use
rapid
detect
atelectasi
pulmonari
complic
periop
recent
vet
blue
profil
dog
undergo
elect
surgic
steril
show
minim
chang
howev
lu
appli
dog
undergo
longer
involv
gener
anesthet
procedur
gallbladd
wall
edema
marker
canin
anaphylaxi
volum
overload
secondari
object
sinc
dog
often
receiv
opioid
intraven
contrast
agent
incit
histamin
releas
splanchnic
venou
pool
occur
gener
anesthesia
method
lung
ultrasound
sonograph
gallbladd
wall
character
postgener
anesthesia
perform
induct
extub
find
dri
lung
glide
sign
wet
lung
consolid
shred
tissu
sign
record
gallbladd
wall
edema
defin
presenc
sonoluc
intralumin
line
gallbladd
thicken
refer
gallbladd
halo
sign
comparison
lu
find
made
postprocedur
spontan
breath
sb
anesthet
mechan
ventil
amv
induct
agent
posit
lu
find
postprocedur
repeat
evalu
perform
result
lung
ultrasound
find
differ
postprocedur
p
wilcoxon
sign
rank
test
sb
n
amv
n
p
induct
agent
p
gallbladd
wall
edema
absent
dog
morphin
includ
sever
dog
associ
vomit
administ
intraven
contrast
agent
dog
posit
lu
find
postprocedur
resolut
lu
find
within
hour
conclus
lung
ultrasound
find
lung
atelectasi
appar
postprocedur
resolut
occur
within
hour
postextub
induct
agent
although
statist
signific
higher
frequenc
abnorm
lu
find
compar
agent
gallbladd
wall
edema
occur
morphin
without
associ
vomit
contrast
agent
venou
splanchnic
pool
find
import
interpret
lu
sonograph
gallbladd
find
periop
distinguish
expect
lu
gallbladd
wall
find
versu
complic
lisciandro
romero
fosgat
countri
veterinari
specialist
spicewood
tx
usa
pretoria
onderstepoort
south
africa
introduct
lung
ultrasound
lu
effect
diagnos
common
respiratori
condit
peopl
establish
frequenc
lu
artifact
puppi
kitten
unknown
greater
total
bodi
water
could
higher
confus
lu
interpret
thu
object
studi
determin
expect
frequenc
lu
artifact
puppi
kitten
method
lung
ultrasound
perform
healthi
puppi
kitten
number
locat
lu
sign
shred
tissu
nodul
wedg
record
data
includ
breed
bodi
condit
score
bc
age
sex
weight
number
per
hemithorax
lu
view
sign
record
lung
ultrasound
find
evalu
rel
bc
weight
sex
left
right
hemithorac
lu
view
result
anim
enrol
puppi
kitten
puppi
includ
chihuahua
labrador
retriev
mix
breed
male
femal
kitten
includ
domest
domest
male
femal
mean
rang
bc
scale
age
week
weight
kg
puppi
respect
total
number
per
hemithorax
left
right
side
posit
view
left
cranial
n
right
cranial
lung
region
n
mean
rang
bc
age
weight
kitten
respect
total
number
per
hemithorax
left
right
side
posit
view
left
caudodors
n
right
caudodors
n
perihilar
n
middl
lung
region
n
posit
view
singl
present
age
bc
weight
sex
significantli
differ
compar
puppi
kitten
versu
without
howev
anim
significantli
younger
p
combin
singl
analysi
conclus
healthi
puppi
kitten
age
week
similar
lu
profil
adult
howev
anim
younger
frequenc
may
higher
week
age
lyon
bm
stefanovski
silverstein
dc
univers
pennsylvania
philadelphia
pa
usa
introduct
past
decad
syndrom
sepsi
defin
system
inflammatori
respons
sir
infect
definit
dog
clinic
recogn
sepsi
met
sir
criteria
although
sir
criteria
previous
consid
sensit
specif
sepsi
recent
evid
call
question
sensit
score
system
well
advent
human
critic
care
redefin
sepsi
organ
dysfunct
caus
dysregul
host
respons
infect
prompt
recommend
sequenti
organ
failur
assess
sofa
score
use
lieu
sir
recogn
patient
infect
develop
sepsi
advent
new
definit
sepsi
human
literatur
beg
question
defin
sepsi
critic
ill
canin
patient
goal
studi
evalu
physic
paramet
clinicopatholog
abnorm
may
help
better
identifi
patient
infect
higher
risk
mortal
method
prospect
observ
studi
dog
admit
icu
elig
admiss
except
patient
recov
anesthesia
icu
postop
discharg
gener
ward
within
hour
blood
work
obtain
discret
primari
clinician
result
one
hundr
dog
enrol
document
evid
infect
mortal
predict
score
gener
use
surviv
outcom
mentat
heart
rate
auroc
compar
favor
sir
auroc
well
appleful
auroc
applefast
auroc
popul
conclus
new
score
system
determin
predict
mortal
hospit
dog
infect
prospect
evalu
larger
patient
cohort
would
help
valid
score
may
also
reveal
paramet
may
predict
mortal
organ
dysfunct
canin
infect
mastrocco
drobatz
reinek
anim
medic
center
new
york
ny
usa
pennsylvania
philadelphia
pa
usa
introduct
goal
studi
evalu
whether
time
surgeri
affect
transfus
requir
length
hospit
cost
outcom
dog
spontan
hemoperitoneum
hypothes
dog
delay
time
surgeri
would
receiv
blood
product
increas
morbid
mortal
compar
dog
earli
surgic
intervent
method
medic
record
dog
surgic
treat
spontan
hemoperitoneum
review
time
admiss
surgic
intervent
volum
blood
transfus
product
administ
mlkg
length
hospit
hour
outcom
surviv
hospit
discharg
death
euthanasia
total
cost
record
data
present
median
rang
result
one
hundr
dog
includ
studi
dog
surgeri
within
hour
admiss
within
hour
within
hour
surgeri
greater
hour
admiss
pack
cell
volum
total
solid
gdl
base
excess
valu
measur
admiss
associ
need
transfus
studi
p
differ
group
overal
dose
mlkg
pack
red
blood
cell
fresh
frozen
plasma
administ
hospit
dog
surgeri
within
hour
admiss
receiv
significantli
greater
number
blood
product
transfus
intraop
compar
dog
hour
group
p
hour
group
p
delay
surgeri
significantli
associ
increas
length
hospit
p
effect
time
surgeri
cost
hospit
patient
outcom
conclus
retrospect
studi
evalu
dog
spontan
hemoperitoneum
delay
surgic
manag
led
significantli
increas
length
hospit
affect
overal
transfus
requir
outcom
find
provid
justif
prospect
evalu
effect
surgic
time
outcom
dog
spontan
hemoperitoneum
pavlid
lynch
snowden
leissing
florida
gainesvil
fl
usa
carolina
state
univers
raleigh
nc
usa
introduct
clinic
patholog
profici
emerg
veterinarian
consid
low
accur
diagnost
essenti
case
manag
aim
studi
determin
whether
emerg
train
cours
clinic
patholog
improv
profici
confid
nonclin
patholog
hous
offic
method
prospect
blind
studi
perform
use
teach
materi
deriv
histor
clinic
specimen
postcours
question
examin
taken
studi
particip
along
assess
confid
level
use
novel
score
system
rang
low
high
result
studi
complet
peopl
didact
train
onlin
lectur
combin
didact
onlin
learn
test
result
significantli
improv
cours
precours
mean
postcours
mean
p
improv
specif
studi
area
hematolog
precours
mean
postcours
mean
p
urinalysi
precours
mean
postcours
mean
p
fluid
analysi
precours
mean
postcours
mean
p
also
signific
increas
studi
particip
clinic
patholog
confid
score
train
precours
mean
postcours
p
conclus
studi
identifi
train
cours
deliv
either
via
didact
prerecord
onlin
lectur
improv
knowledg
confid
nonclin
patholog
hous
offic
similar
train
cours
may
prove
help
futur
improv
clinic
patholog
skill
small
anim
emerg
veterinarian
rodrigu
branco
viega
ferreira
martin
de
portug
lisbon
portug
de
lisboa
lisbon
portug
introduct
sepsi
hard
defin
syndrom
associ
deleteri
system
inflammatori
respons
ultim
lead
coagulopathi
organ
dysfunct
death
primari
aim
prospect
studi
evalu
coagul
time
predict
diseas
sever
outcom
patient
risk
develop
sepsi
secondari
object
correl
activ
partial
thromboplastin
time
aptt
prothrombin
time
pt
quick
sequenti
organ
failur
assess
qsofa
score
system
moment
admiss
intens
care
unit
icu
evalu
combin
prognost
valu
method
total
dog
prospect
enrol
studi
septemb
march
patient
hemodynam
alter
clinic
sign
coagulopathi
infect
shock
sir
includ
well
affect
polytrauma
organ
dysfunct
neoplasia
upon
present
patient
suscept
subclin
infect
bacteri
transloc
therefor
risk
develop
sepsi
coagul
test
qsofa
score
perform
time
admiss
icu
statist
analyz
use
descript
inferenti
analys
variabl
signal
diagnosi
durat
hospit
postdischarg
treatment
outcom
also
record
analyz
result
mortal
rate
mortal
increas
number
qsofa
point
point
point
point
point
aptt
significantli
higher
p
patient
qsofa
score
point
comparison
point
posit
correl
found
aptt
pt
r
n
p
mean
valu
aptt
pt
similar
surviv
nonsurviv
patient
ten
patient
die
first
fifth
day
treatment
remain
death
caus
neoplast
diseas
conclus
result
studi
suggest
exist
hemostat
dysfunct
amongst
patient
qsofa
score
point
isol
howev
prolong
coagul
time
icu
admiss
predict
outcom
roux
fa
c
deschamp
jy
colleg
veterinari
medicin
nant
franc
introduct
gastric
foreign
bodi
convent
manag
endoscop
extract
gastrotomi
method
studi
examin
result
noninvas
techniqu
manag
gastric
foreign
bodi
popul
dog
present
emerg
depart
januari
march
popul
includ
dog
present
ingest
foreign
bodi
dog
gastric
foreign
bodi
identifi
imag
practic
favor
oral
evacu
techniqu
consist
give
larg
meal
induc
vomit
emet
substanc
apomorphin
hydrogen
peroxid
solut
exert
pressur
abdomen
vomit
name
procedur
heimlich
maneuv
refer
procedur
describ
hj
heimlich
airway
obstruct
peopl
case
failur
option
consid
endoscop
extract
gastrotomi
result
one
hundr
seventeen
dog
identifi
initi
induc
vomit
conjunct
heimlich
maneuv
attempt
dog
dog
vomit
allow
extract
foreign
bodi
vomit
dog
surveil
without
intervent
elect
dog
dog
underw
endoscop
extract
dog
underw
extract
gastrostomi
subsequ
among
dog
foreign
bodi
recov
dog
vomit
dog
vomit
heimlich
maneuv
produc
foreign
bodi
dog
total
gastric
foreign
bodi
receiv
treatment
dog
underw
endoscop
extract
dog
underw
gastrotomi
total
induct
vomit
associ
heimlich
maneuv
result
extract
gastric
foreign
bodi
approach
suffic
noninvas
manag
therefor
effect
case
case
requir
intervent
endoscop
extract
gastrotomi
conclus
propos
novel
simpl
minim
invas
often
effect
extract
techniqu
gastric
foreign
bodi
dog
techniqu
approach
consid
endoscopi
gastrotomi
attempt
roux
fa
troussier
gc
deschamp
oniri
veterinari
medicin
school
nant
franc
introduct
symmetr
dimethylarginin
sdma
consid
biomark
earli
detect
renal
dysfunct
case
acut
kidney
injuri
aki
present
studi
exist
analyz
relev
sdma
cat
aki
hypothes
sdma
would
correctli
identifi
cat
acut
renal
diseas
valu
would
correl
iri
grade
cat
urethr
obstruct
uo
method
cat
uo
present
emerg
servic
compar
healthi
compar
cat
urea
creatinin
potassium
sdma
measur
admiss
cat
uo
classifi
accord
iri
aki
grade
scale
nonparametr
statist
analysi
perform
result
median
urea
creatinin
sdma
concentr
higher
uo
group
compar
control
group
sdmacreatinin
ratio
differ
regard
cat
uo
control
group
sdma
highli
correl
creatinin
r
p
median
sdma
concentr
refer
rang
iri
stage
stage
compar
iri
group
iri
n
iri
n
iri
n
iri
n
iri
n
urea
creatinin
sdma
highli
differ
group
wherea
potassium
sdmacreatinin
iri
iri
uo
cat
compar
median
urea
creatinin
potassium
sdma
concentr
higher
iri
uo
group
compar
iri
group
sdmacreatinin
ratio
differ
cat
aliv
day
postdischarg
cat
aliv
year
urea
creatinin
potassium
sdma
sdmacreatinin
ratio
differ
aliv
deceas
cat
aliv
cat
cat
recurr
uo
three
cat
initi
iri
none
studi
paramet
includ
sdma
sdmacreatinin
ratio
differ
regard
recurr
uo
episod
conclus
plasma
sdma
concentr
suitabl
marker
identifi
aki
uo
cat
sdma
correl
iri
stage
sdmacreatinin
ratio
sowi
jefferi
ul
rutter
c
texa
univers
colleg
station
tx
usa
introduct
hemoperitoneum
common
find
dog
emerg
set
may
necessit
use
blood
product
autotransfus
could
reduc
cost
mitig
advers
transfus
reaction
howev
shed
hemothorax
blood
human
trauma
patient
contain
high
concentr
potenti
detriment
procoagul
phosphatidylserin
posit
microparticl
object
studi
compar
phosphatidylserin
posit
microparticl
concentr
procoagul
activ
canin
hemoperitoneum
fluid
pack
red
blood
cell
unit
prbc
method
ten
dog
hemoperitoneum
neoplasia
trauma
recruit
prbc
unit
purchas
supernat
collect
hemoperitoneum
prbc
sampl
phosphatidylserin
posit
microparticl
concentr
measur
via
flow
cytometri
procoagul
activ
commerci
thrombin
gener
assay
result
concentr
phosphatidylserin
posit
microparticl
significantli
differ
prbc
median
rang
hemoperitoneum
sampl
median
rang
p
procoagul
activ
significantli
higher
supernat
collect
prbc
median
nm
rang
nm
hemoperitoneum
sampl
median
nm
rang
nm
p
conclus
find
suggest
shed
hemoperitoneum
blood
contain
phosphatidylserin
posit
microparticl
higher
procoagul
activ
prbc
unit
measur
procoagul
proinflammatori
microparticl
compon
investig
effect
autotransfus
versu
prbc
transfus
circul
microparticl
concentr
warrant
spada
e
perego
r
baggiani
l
martino
pa
proverbio
univers
milan
milan
itali
introduct
increas
access
veterinari
hospit
blood
bank
commerci
sourc
felin
blood
product
mean
transfus
therapi
wide
avail
veterinarian
felin
store
blood
product
use
often
despit
increas
avail
felin
blood
collect
store
transfus
purpos
studi
investig
storag
lesion
felin
whole
blood
fwb
unit
studi
evalu
hematolog
chang
fwb
unit
object
studi
assess
chang
felin
rbc
collect
store
transfus
purpos
fwb
unit
method
prospect
laboratori
vitro
studi
conduct
twelv
nonleukoreduc
fwb
unit
collect
open
system
use
three
syring
prefil
citrat
phosphat
dextros
adenin
solut
ratio
blood
anesthet
felin
blood
donor
unit
store
blood
bank
dedic
refriger
sampl
everi
day
collect
end
storag
day
time
point
follow
evalu
hematolog
paramet
rbc
hgb
hct
mcv
mch
mchc
rdw
percentag
hemolysi
morpholog
index
score
base
echinocyt
transform
normal
discocyt
aerob
anaerob
blood
cultur
result
statist
compar
wilcoxon
test
appropri
statist
signific
set
p
result
signific
differ
hematolog
paramet
time
point
respect
signific
increas
found
percentag
hemolysi
morpholog
index
start
day
storag
p
p
respect
mean
hemolysi
percentag
valu
less
day
storag
blood
cultur
neg
bacteri
growth
conclus
rbc
fwb
unit
collect
open
system
undergo
signific
hematolog
chang
result
suggest
storag
day
safe
vivo
studi
requir
establish
chang
affect
abil
store
rbc
circul
provid
adequ
oxygen
deliveri
transfus
taylor
aq
gladden
jn
wayn
tuft
univers
north
grafton
usa
introduct
standard
method
nasogastr
tube
ngt
placement
veterinari
medicin
mani
place
blindli
blind
techniqu
result
tracheal
pulmonari
pleural
malposit
wherein
complic
may
develop
case
tracheopulmonari
misplac
report
dog
human
result
death
although
radiograph
assess
ngt
placement
reliabl
indic
posit
recognit
ngt
malposit
tube
fulli
advanc
prevent
pulmonari
complic
limit
complic
later
cervic
radiograph
recommend
recent
veterinari
literatur
verifi
correct
tube
placement
larynx
within
esophagu
prior
ngt
advanc
final
posit
goal
studi
assess
whether
standard
protocol
incorpor
later
cervic
radiograph
could
correctli
identifi
ngt
tracheal
misplac
prior
tube
advanc
method
prospect
studi
perform
veterinari
teach
hospit
decemb
april
follow
ngt
placement
questionnair
includ
follow
inform
patient
factor
reason
placement
mentat
recumb
head
conform
placement
nostril
evid
cough
andor
swallow
time
placement
use
sedat
gener
anesthesia
tube
factor
size
presenc
stylet
placement
factor
clinician
experi
number
attempt
time
placement
number
radiograph
obtain
presenc
misplac
complet
attend
clinician
result
total
ngt
placement
dog
cat
tracheal
misplac
dog
cat
identifi
tube
fulli
advanc
anim
sternal
recumb
neither
receiv
sed
dog
note
brachycephal
confirm
alert
mentat
cat
report
mesocephal
quiet
mentat
tube
place
resid
cough
report
evid
swallow
describ
case
conclus
use
standard
protocol
incorpor
later
cervic
radiograph
identifi
ngt
tracheal
misplac
case
blind
techniqu
safeti
assess
includ
lack
swallow
presenc
cough
fail
alert
clinician
tube
malposit
thevelein
bal
koenig
brainard
bm
univers
georgia
athen
ga
usa
introduct
rapid
accur
measur
hematocrit
use
small
sampl
volum
use
critic
ill
patient
interfer
substanc
blood
eg
lipemia
may
influenc
function
machin
reli
optic
measur
aim
evalu
precis
accuraci
veterinari
poc
hematocrit
meter
studi
effect
potenti
confound
variabl
meter
function
hypothes
meter
accur
precis
wide
rang
hematocrit
confound
would
affect
meter
function
method
canin
felin
venou
whole
blood
edta
sampl
n
run
duplic
poc
report
hemoglobin
pochb
measur
via
optic
reflect
calcul
hematocrit
pochct
meter
result
compar
result
analyz
cbc
sampl
grossli
visibl
lipemia
icteru
hemolysi
note
result
cbc
hematocrit
rang
mean
hemoglobin
concentr
rang
gdl
mean
gdl
averag
differ
duplic
pochct
duplic
pochb
valu
gdl
respect
good
correl
meter
cbc
hematocrit
r
hemoglobin
r
appar
influenc
visibl
lipemia
n
icteru
n
hemolysi
n
meter
accuraci
poc
fail
read
sampl
mark
hematocrit
conclus
overal
poc
excel
precis
correl
cbc
meter
influenc
icteru
lipemia
hemolysi
provid
data
sampl
hematocrit
torrent
artero
manzanilla
bosch
pastor
ruiz
de
gopegui
de
barcelona
barcelona
spain
research
centr
cork
ireland
de
murcia
murcia
spain
introduct
investig
diagnost
prognost
valu
plasma
adiponectin
adpn
concentr
versu
tradit
inflammatori
biomark
admiss
icu
stay
dog
affect
natur
sepsi
method
observ
prospect
observ
studi
includ
critic
ill
dog
clinic
evid
system
inflammatori
respons
syndrom
sir
infecti
origin
admiss
plasma
adpn
albumin
alb
protein
crp
ferritin
frt
haptoglobin
hap
fibrinogen
fbg
measur
upon
sepsi
diagnosi
everi
hour
death
discharg
dog
local
inflamm
healthi
dog
includ
studi
posit
neg
control
group
respect
studi
variabl
compar
among
group
use
gener
linear
model
valu
also
compar
outcom
group
anim
septic
group
alpha
level
signific
result
expect
anim
local
inflamm
n
sepsi
n
group
lower
adpn
alb
higher
crp
fbg
frt
level
control
anim
n
admiss
dog
sepsi
lower
adpn
vs
p
alb
vs
gdl
p
higher
crp
vs
p
concentr
dog
local
inflamm
regard
initi
final
adpn
concentr
septic
dog
signific
differ
outcom
detect
group
p
conclus
adiponectin
may
reliabl
marker
sepsi
chang
relat
sever
diseas
progress
inflammatori
respons
dog
howev
studi
warrant
confirm
prognost
valu
inflammatori
marker
torrent
artero
manzanilla
bosch
pastor
ruiz
de
gopegui
de
barcelona
barcelona
spain
research
centr
cork
spain
de
murcia
murcia
spain
introduct
evalu
diagnost
prognost
valu
plasma
paraoxonas
concentr
butyrylcholinesteras
bche
activ
versu
tradit
inflammatori
biomark
admiss
icu
stay
dog
affect
natur
sepsi
method
observ
prospect
studi
includ
critic
ill
dog
clinic
evid
infecti
sir
admiss
plasma
bche
albumin
alb
protein
crp
measur
upon
sepsi
diagnosi
everi
hour
patient
death
discharg
dog
local
inflamm
healthi
dog
includ
studi
posit
neg
control
group
respect
studi
variabl
compar
among
group
use
gener
linear
model
valu
also
compar
outcom
group
anim
septic
group
alpha
level
signific
result
anim
local
inflamm
n
sepsi
n
group
lower
higher
bche
activ
control
anim
n
admiss
dog
sepsi
lower
vs
uiml
p
dog
local
inflamm
differ
bche
activ
vs
p
septic
dog
correl
applefast
score
bche
activ
r
p
r
p
respect
septic
dog
differ
outcom
paramet
detect
popul
submit
studi
conclus
conclus
present
studi
identifi
lower
serum
higher
bche
activ
septic
dog
studi
warrant
describ
bche
activ
potenti
use
marker
sepsi
progress
recoveri
vose
j
odunayo
price
j
schildt
j
dave
tolbert
mk
univers
tennesse
knoxvil
tn
usa
introduct
determin
whether
heparin
salin
would
effect
maintain
patenc
central
venou
cathet
cvc
dog
compar
sodium
chlorid
method
healthi
dog
random
group
treatment
control
group
central
venou
cathet
place
jugular
vein
dog
dog
treatment
group
cvc
flush
iuml
heparin
salin
dog
control
group
cvc
flush
sodium
chlorid
everi
hour
hour
immedi
prior
flush
cathet
evalu
patenc
aspir
blood
cathet
site
also
evalu
phlebiti
rectal
temperatur
obtain
dog
everi
hour
blood
sampl
obtain
dog
hour
evalu
pt
aptt
valu
group
result
cvc
group
patent
hour
demonstr
aspir
blood
eas
flush
cathet
two
cvc
sodium
chlorid
group
neg
aspir
hour
respect
one
cvc
heparin
salin
group
neg
aspir
hour
sign
phlebiti
occur
dog
sodium
chlorid
group
heparin
salin
group
dog
hypertherm
two
cathet
inadvert
remov
studi
heparin
salin
group
signific
differ
pt
valu
aptt
valu
dog
either
group
conclus
sodium
chlorid
effect
iuml
heparin
salin
maintain
central
venou
cathet
hour
healthi
dog
evalu
clinic
patient
warrant
sage
bedenic
long
mazan
mckinney
paradi
wagner
school
veterinari
medicin
tuft
univers
north
grafton
usa
univers
ithaca
ny
usa
introduct
studi
assess
whether
age
hors
coliti
diarrhea
show
greater
diseas
morbid
system
inflammatori
respons
mortal
similarli
affect
hors
method
retrospect
cohort
analysi
includ
hospit
hors
diagnos
coliti
diarrhea
determin
potenti
effect
patient
age
diseas
progress
mortal
subset
hors
n
diarrhea
evalu
prospect
identifi
chang
coagul
inflammatori
biomark
earli
diseas
prospect
analys
time
diarrhea
onset
hour
later
includ
cbc
plasma
lactat
hors
cytokin
assay
univari
multivari
statist
test
use
detect
identifi
paramet
affect
surviv
discharg
retrospect
analysi
p
result
surviv
coliti
hors
significantli
younger
median
age
year
nonsurviv
hors
year
retrospect
assess
increas
mortal
year
hors
age
similarli
geriatr
hors
year
significantli
like
die
year
despit
higher
financi
invest
hospit
care
longer
hospit
multivari
outcom
analysi
plasma
transfus
fecal
transplant
associ
outcom
none
inflammatori
biomark
significantli
differ
age
hors
prospect
assess
conclus
data
support
outcom
coliti
less
favor
geriatr
versu
hors
explain
differ
measur
inflammatori
respons
earli
diseas
kopper
bolger
schott
state
univers
pullman
wa
usa
state
univers
lans
mi
usa
introduct
intraven
fluid
import
compon
fluid
therapi
critic
ill
equin
patient
unfortun
commerci
avail
mainten
formula
avail
hors
addit
recent
challeng
includ
manufactur
shortag
increas
cost
made
treat
hors
intraven
fluid
challeng
best
one
solut
hospit
use
nonsteril
revers
osmosi
water
custom
electrolyt
formula
hypothes
hors
receiv
nonsteril
iv
fluid
jug
would
increas
rate
morbid
mortal
compar
hors
receiv
tradit
intraven
fluid
ivf
method
medic
record
hors
michigan
state
univers
veterinari
medic
center
receiv
jug
ivf
decemb
august
review
data
retriev
includ
signal
type
fluid
administ
hematolog
evalu
develop
complic
surviv
discharg
surviv
compar
analysi
normal
numer
data
assess
use
test
compar
anova
anova
rank
use
post
hoc
holm
sidak
test
dunn
test
result
total
hors
includ
receiv
ivf
receiv
jug
differ
surviv
discharg
hors
receiv
jug
versu
ivf
vs
p
increas
incid
jugular
vein
complic
vs
p
lamin
vs
p
hors
receiv
jug
vs
hors
receiv
ivf
conclus
administr
jug
affect
surviv
discharg
howev
associ
jugular
vein
complic
lamin
warrant
inform
discuss
owner
prior
util
dixon
bedenic
brewer
knafo
mazan
restifo
glasgow
glasgow
uk
univers
north
grafton
usa
equin
medic
center
brandon
fl
usa
zoo
mendon
usa
bank
veterinari
hospit
tinton
fall
nj
usa
introduct
studi
purpos
describ
clinicopatholog
find
diagnos
treatment
outcom
newborn
giraff
calv
experienc
neonat
ill
method
retrospect
cohort
analysi
neonat
giraff
calv
admit
univers
teach
hospit
data
present
descript
result
ten
calv
male
femal
reticul
giraff
giraffa
cameloparadali
reticulata
masai
giraff
g
c
tippelskirchi
admit
less
day
age
failur
passiv
transfer
fpt
evid
calv
base
assess
serum
protein
globulin
transferas
success
treat
oral
bovin
colostrum
hyperimmun
bovin
plasma
intraven
diarrhea
occur
calv
manag
support
care
fecal
transfaun
limit
milk
intak
incid
diarrhea
reduc
offer
bodi
weight
milk
per
day
interv
l
per
feed
less
common
diagnos
includ
pneumonia
n
septic
arthriti
n
eight
calv
receiv
system
antimicrobi
therapi
hyperlactatemia
lactat
mmoll
n
hypercreatininemia
creatinin
mgdl
n
common
present
laboratori
abnorm
resolv
intraven
fluid
therapi
neonat
giraff
surviv
discharg
follow
median
hospit
day
rang
success
conclus
earli
bovin
colostrum
administr
intraven
hyperimmun
bovin
plasma
infus
manag
fpt
well
toler
diarrhea
common
clinic
problem
relat
feed
regimen
hospit
neonat
giraff
calv
may
carri
excel
prognosi
follow
earli
intervent
gordon
alshahrani
cebra
christensen
duong
huang
stang
univers
palmerston
north
new
zealand
state
univers
corval
usa
limit
new
brunswick
usa
introduct
gamithromycin
antimicrobi
concentr
neutrophil
respiratori
tract
rumin
gamithromycin
therefor
consid
potenti
antimicrobi
candid
camelid
might
also
improv
owner
anim
complianc
due
infrequ
dose
studi
object
determin
disposit
gamithromycin
plasma
peripher
blood
neutrophil
pmn
pulmonari
epitheli
line
fluid
pelf
bronchoalveolar
lavag
bal
cell
alpaca
method
singl
subcutan
inject
gamithromycin
mgkg
bodi
weight
administ
healthi
adult
alpaca
gamithromycin
concentr
analyz
via
plasma
polymorphonuclear
cell
pulmonari
epitheli
line
fluid
bronchoalveolar
lavag
cell
day
plasma
gamithromycin
measur
alpaca
remain
bodi
compart
analyz
alpaca
result
gamithromycin
rapidli
concentr
blood
pmn
bal
cell
pelf
tmax
cmax
auc
lower
plasma
three
compart
mean
peak
gamithromycin
concentr
highest
bal
cell
ngml
pmn
ngml
compar
pelf
ngml
plasma
ngml
mean
termin
hour
plasma
hour
pelf
hour
pmn
hour
bal
cell
inject
site
reaction
occur
one
alpaca
develop
colic
conclus
gamithromycin
concentr
significantli
white
blood
cell
pulmonari
tissu
alpaca
expect
studi
necessari
determin
clinic
safeti
identifi
mic
data
bacteri
isol
origin
camelid
moyano
parra
gomez
neito
leon
montoya
pared
higuera
salazar
ce
medellin
colombia
florida
gainesvil
fl
usa
de
antioquia
medellin
colombia
de
tolima
ibagu
colombia
universitaria
la
sallista
medellin
colombia
introduct
studi
aim
explor
differ
caus
gastrointestin
colic
hors
colombia
method
medic
record
hors
refer
teach
hospit
colic
review
final
diagnosi
achiev
physic
examin
rectal
palpat
nasogastr
intub
blood
work
abdominocentesi
exploratori
laparotomi
necropsi
exam
result
total
record
hors
colic
includ
three
hundr
hors
paso
fino
breed
surgic
medic
case
identifi
larg
colon
impact
common
caus
colic
n
follow
small
colon
impact
n
common
caus
surgic
colic
larg
colon
impact
n
small
colon
impact
n
small
intestin
strangul
obstruct
n
common
caus
medic
colic
larg
colon
impact
n
small
colon
impact
n
overal
surviv
rate
n
hors
euthan
die
clinic
complic
surgic
case
n
surviv
n
euthan
n
die
medic
treat
colic
case
n
case
surviv
n
euthan
n
die
conclus
high
proport
paso
fino
hors
colic
consist
popul
present
hospit
surviv
rate
similar
group
compar
previou
studi
worldwid
rate
hors
larg
colon
impact
requir
surgeri
higher
previous
report
someth
warrant
investig
scicluna
c
equiinstitut
chamant
franc
introduct
last
year
miniatur
allow
portabl
easier
use
numer
tool
veterinari
practic
follow
introduct
epoc
devic
market
edan
brand
new
poct
devic
design
human
veterinari
blood
gase
biochem
analysi
use
critic
routin
situat
field
method
epoc
compar
equin
clinic
routin
examin
gener
anesthesia
reliabl
easi
use
price
rapid
thirti
venou
arteri
blood
sampl
analyz
epoc
machin
simultan
blood
ph
abe
na
k
ht
hb
glucos
lactat
valu
compar
student
p
signific
analysi
time
easi
use
failur
also
evalu
result
epoc
result
higher
obtain
reach
statist
signific
except
k
vs
vs
vs
epoc
respect
paramet
panel
wider
includ
anion
gap
h
osmolar
ri
aa
ratio
easi
use
need
prepar
wait
time
inject
sampl
cartridg
total
analysi
time
shorter
printer
larg
display
screen
make
machin
easier
read
interpret
result
sampl
cartridg
cheaper
need
store
fridg
make
conveni
conclus
epoc
devic
portabl
easi
use
equin
practic
offer
reliabl
result
paramet
routin
anesthesia
blood
gase
chemistri
analysi
pared
higuera
ariza
moyano
parra
zambrano
cardona
de
antioquia
medellin
colombia
ce
medellin
colombia
la
sall
bogata
colombia
introduct
plasma
transfus
pt
common
therapeut
procedur
septic
foal
foal
failur
transfer
passiv
immun
ftpi
incid
pt
reaction
fresh
plasma
use
vari
studi
aim
explor
incid
pt
reaction
foal
ftpi
receiv
fresh
plasma
teach
hospit
colombia
method
medic
record
foal
receiv
fresh
plasma
transfus
due
ftpi
review
ftpi
defin
total
failur
igg
level
mgdl
partial
igg
level
mgdl
result
foal
includ
foal
paso
fino
poni
breed
quarter
hors
breed
median
age
present
hour
rang
hour
median
weight
kg
rang
kg
median
volum
plasma
transfus
l
rang
l
compat
major
minor
test
perform
n
case
overal
immedi
reaction
observ
case
includ
fever
n
tachycardia
n
tachypnea
n
tremor
n
diarrhea
n
total
foal
die
reason
associ
plasma
transfus
conclus
studi
pt
reaction
rate
higher
previous
report
could
explain
least
part
low
rate
compat
test
gilliam
bulfon
gilliam
lewin
samuel
state
univers
stillwat
ok
usa
elizabeth
hospit
king
lynn
unit
kingdom
san
francisco
ca
usa
introduct
worldwid
approxim
peopl
die
annual
due
snake
envenom
livestock
companion
anim
mortal
number
like
higher
venom
ubiquit
among
viper
elapid
venom
lethal
compon
major
snake
venom
neurotox
coagulopathi
primari
mechan
major
snake
venom
caus
death
antivenom
avail
hospit
set
requir
refriger
snakebit
death
occur
outsid
hospit
ideal
antidot
snake
envenom
would
venom
agnost
heat
stabl
readili
avail
easi
administ
even
outsid
hospit
studi
util
porcin
model
investig
abil
small
molecul
prevent
mortal
due
experiment
lethal
micruru
fulviu
envenom
method
pig
anesthet
instrument
subcutan
envenom
lethal
dose
micruru
fulviu
venom
control
pig
receiv
excipi
treatment
pig
receiv
drug
one
three
rout
follow
envenom
intraven
iv
constant
rate
infus
cri
plu
oral
po
variou
dosesfrequ
laboratori
sampl
collect
baselin
time
point
follow
envenom
clinic
lame
score
system
util
subject
receiv
analgesia
euthan
accord
predetermin
criteria
result
control
pig
reach
clinic
score
warrant
euthanasia
within
hour
one
hundr
percent
pig
treatment
categori
surviv
clinic
normal
end
studi
advers
effect
drug
note
conclus
antidot
show
great
promis
treat
snakebit
envenom
shearer
holcomb
fogl
lynch
morresey
shroeder
southwood
state
univers
lans
mi
usa
carolina
state
univers
raleigh
nc
usa
state
univers
columbu
oh
usa
pennsylvania
kennett
squar
pa
usa
smith
equin
hospit
ocala
fl
usa
riddl
equin
hospit
lexington
ky
usa
introduct
ethyl
pyruv
use
preclin
model
gastrointestin
ischemia
sepsi
improv
tissu
heal
surviv
mitig
oxid
damag
inflamm
ethyl
pyruv
shown
safe
effect
equin
endotoxemia
model
object
studi
evalu
efficaci
ethyl
pyruv
clinic
case
follow
surgic
correct
larg
colon
volvulu
method
random
multicent
prospect
studi
hors
receiv
either
mgkg
ethyl
pyruv
lr
lr
everi
hour
hour
follow
recoveri
surgic
correct
lcv
hr
pcv
monitor
hour
blood
sampl
proinflammatori
cytokin
gene
express
treatment
preliminari
descript
statist
perform
result
twelv
hors
enrol
six
hors
receiv
ethyl
pyruv
admiss
median
rang
hr
min
pcv
mmoll
hour
postop
hr
min
pcv
mmoll
four
hors
surviv
discharg
six
hors
receiv
lr
admiss
median
hr
min
pcv
mmoll
hour
postop
hr
min
pcv
mmoll
three
hors
surviv
discharg
advers
event
associ
ethyl
pyruv
occur
conclus
enrol
addit
case
allow
us
determin
effect
ethyl
pyruv
postop
outcom
hors
lcv
munoz
holcomb
hubbel
robertson
szarek
state
univers
lans
mi
usa
love
gainesvil
fl
usa
riddl
equin
hospit
lexington
ky
usa
introduct
cardiovascularli
compromis
hors
anesthet
surgic
correct
ischem
intestin
lesion
frequent
hors
suffer
diminish
oxygen
deliveri
compound
anesthet
drug
ethyl
pyruv
prometabol
antioxid
divers
pharmacolog
effect
limit
ischem
tissu
injuri
hasten
tissu
recoveri
previou
termin
studi
show
ethyl
pyruv
significantli
increas
cardiac
output
oxygen
deliveri
central
venou
pressur
compar
valu
control
hors
receiv
lr
hypothes
ethyl
pyruv
would
improv
cardiopulmonari
paramet
anesthet
hors
neg
effect
anesthet
recoveri
method
six
standardbr
geld
enrol
random
crossov
design
hors
anesthet
minut
receiv
l
lr
mgkg
ethyl
pyruv
l
lr
minut
direct
arteri
pressur
hr
rr
record
everi
minut
arteri
blood
gase
assess
everi
minut
anesthet
recoveri
record
score
two
blind
observ
total
recoveri
time
time
extub
time
sternal
recumb
number
attempt
stand
time
stand
record
data
assess
univari
test
p
treatment
time
fix
effect
result
hors
complet
studi
complic
signific
differ
ethyl
pyruv
treatment
lr
control
detect
anesthesia
recoveri
cardiopulmonari
variabl
measur
conclus
studi
limit
includ
low
hors
number
use
healthi
standardbr
geld
result
suggest
ethyl
pyruv
may
use
anesthet
clinic
case
without
impact
anesthet
recoveri
koch
dw
easley
jt
delcambr
jj
mccreadi
eg
hackett
es
colorado
state
univers
fort
collin
co
usa
introduct
chronic
infect
within
auditori
tube
diverticula
subsequ
empyema
chondroid
format
well
describ
hors
medic
therapi
report
mix
success
treatment
failur
attribut
chronic
inflamm
inadequ
drainag
nasopharyng
ostium
auditori
tube
diverticulotomi
allow
continu
egress
caviti
aim
present
studi
compar
two
transpharyng
endoscop
auditori
tube
diverticulotomi
locat
describ
rel
anatomi
durat
incis
properti
surgic
approach
method
transpharyng
endoscop
auditori
tube
diverticulotomi
perform
use
diod
laser
either
singl
dorsopharyng
recess
locat
bilater
caudal
nasopharyng
ostium
hors
head
specimen
laser
energi
activ
time
procedur
durat
record
use
compar
total
laser
energi
laser
activ
time
surgic
durat
surgic
procedur
result
method
result
clear
commun
nasopharynx
auditori
tube
diverticula
diverticulotomi
perform
dorsal
pharyng
recess
requir
less
laser
energi
activ
time
shorter
surgic
durat
diverticulotomi
perform
caudal
nasopharyng
ostium
conclus
surgic
method
result
clear
commun
pharynx
auditori
tube
diverticula
though
techniqu
differ
locat
diverticulotomi
laser
energi
activ
time
surgic
durat
studi
warrant
rel
clinic
applic
techniqu
willett
kogan
kopper
leutenegg
schott
pennsylvania
kennett
squar
pa
usa
statist
washington
state
univers
pullman
wa
usa
state
univers
pullman
wa
usa
laboratori
sacramento
ca
usa
state
univers
lans
mi
usa
introduct
acut
diarrheal
diseas
enterocol
equin
emerg
determin
etiolog
caus
enterocol
desir
tailor
specif
therapi
hypothes
incid
enter
pathogen
caus
enterocol
would
influenc
season
geograph
region
method
result
equin
enter
diseas
fecal
pcr
panel
submit
idexx
laboratori
adult
hors
januari
decemb
review
panel
test
salmonella
spp
neorickettsia
risticii
clostridium
difficil
type
toxin
clostridium
difficil
type
b
toxin
clostridium
perfringen
type
b
toxin
coronaviru
cryptosporidium
spp
rhodoccu
equi
lawsonia
intracellulari
rotaviru
perform
state
separ
geograph
region
month
group
season
relat
probabl
diseas
geograph
region
season
logist
regress
perform
use
tukey
correct
multipl
comparison
signific
set
p
result
fecal
sampl
test
studi
period
yield
posit
result
signific
differ
incid
cryptosporidium
spp
c
perfringen
salmonella
spp
identifi
geograph
region
incid
rotaviru
r
equi
lawsonia
spp
coronaviru
differ
season
signific
interact
region
season
n
risticii
incid
c
difficil
type
c
difficil
type
b
toxin
affect
geograph
region
season
conclus
incid
cryptosporidium
spp
c
perfringen
salmonella
rotaviru
r
equi
lawsonia
spp
coronaviru
n
risticii
affect
geograph
locat
andor
season
benam
guidi
lefebvr
milard
veterinari
school
lyonmarci
letoil
franc
marci
letoil
franc
introduct
retrospect
studi
conduct
among
popul
hors
refer
primari
colic
order
investig
develop
fever
complic
popul
method
one
hundr
hors
manag
medic
manag
surgic
intens
care
provid
usual
complic
note
includ
recurr
colic
diarrhea
similar
rate
studi
pyrexia
last
hour
also
observ
hospit
hors
medic
colic
surgic
colic
thorough
standard
clinic
investig
fever
carri
exclud
primarili
endotoxemia
periton
enterocol
secondari
pleuropneumonia
thrombiti
examin
includ
cbc
biochemistri
inflammatori
protein
panel
ultrasonograph
exam
abdomen
thorax
vessel
airway
endoscop
examin
periton
fluid
cytolog
necessari
signific
caus
hyperthermia
found
blood
test
hemopathogen
hors
consid
piroplasmosi
posit
babesia
cabal
theileria
equi
base
pcr
posit
seroposit
risk
factor
assess
studi
correl
piroplasmosi
statu
incid
fever
result
among
hors
test
test
piroplasmosi
posit
involv
equi
develop
complic
thrombophleb
least
signific
limb
vascul
respiratori
distress
also
possibl
relat
piroplasmosi
infect
conclus
posit
piroplasmosi
statu
hors
hospit
colic
appear
increas
risk
factor
develop
hyperthermia
complic
statu
import
consid
intens
care
especi
endem
area
baker
cebra
kitada
schlipf
state
univers
baton
roug
la
usa
state
univers
corval
usa
colleg
portland
usa
introduct
lactat
glycolysi
valuabl
marker
critic
ill
sepsi
equin
medicin
lactat
product
vari
differ
bodi
region
howev
littl
inform
regard
product
limb
exist
object
studi
compar
jugular
cephal
plasma
lactat
concentr
healthi
clinic
ill
hors
method
prospect
studi
hors
present
august
februari
clinic
ill
hors
healthi
control
hors
investig
blood
sampl
drawn
jugular
cephal
vein
analysi
present
first
hour
hospit
result
cephal
vein
lactat
significantli
higher
jugular
vein
lactat
healthi
control
hors
p
cephal
vein
lactat
significantli
higher
jugular
vein
lactat
present
clinic
ill
hors
time
point
p
clinic
ill
hors
investig
specif
outcom
survivor
vs
nonsurvivor
lamin
vs
nonlamin
cephal
vein
lactat
significantli
higher
survivor
hors
develop
lamin
p
differ
found
nonsurvivor
hors
develop
lamin
differ
seen
rate
chang
lactat
time
survivor
compar
nonsurvivor
lamin
hors
compar
nonlamin
hors
conclus
signific
differ
jugular
cephal
vein
lactat
product
seen
healthi
clinic
ill
hors
investig
warrant
see
valu
chang
time
cours
clinic
diseas
aem
camdebord
pc
lesca
hc
tourrel
lyon
veterinari
school
lyonmarci
letoil
franc
introduct
heart
rate
variabl
hrv
analysi
relev
indic
cardiac
autonom
control
aim
studi
assess
one
main
paramet
hrv
root
mean
squar
success
differ
rmssd
use
indic
pain
hors
suffer
colic
materi
hors
hospit
colic
enrol
hors
studi
daili
least
day
set
quiet
time
make
measur
via
heart
rate
monitor
polar
determin
pain
score
dalla
costa
grimac
pain
score
gp
composit
pain
scale
cp
minut
observ
data
analyz
special
softwar
kubio
obtain
rmssd
nonparametr
statist
analysi
conduct
analysi
variancecorrel
result
case
show
posit
evolut
accord
gsc
cp
eight
among
medic
surgic
colic
demonstr
rmssd
clearli
increas
pain
score
decreas
mark
increas
rmssd
ms
note
hors
pain
reach
zero
score
end
hospit
similarli
mark
trend
also
observ
surgic
case
gsc
cp
score
decreas
rmssd
valu
conclus
preliminari
data
chang
rmssd
colic
manag
show
trend
mark
tend
correl
pain
score
data
necessari
establish
possibl
signific
improv
experiment
design
long
barr
bedenic
burn
dembeck
magdesian
olson
sanchez
slovi
rubi
wong
paradi
wilken
school
veterinari
medicin
tuft
univers
north
grafton
usa
state
univers
ame
ia
usa
riddl
equin
hospit
lexington
ky
usa
state
univers
columbu
oh
usa
florida
gainesvil
fl
usa
equin
medic
institut
lexington
ky
usa
california
davi
ca
usa
univers
ithaca
ny
usa
illinoi
urbana
il
usa
introduct
studi
assess
prognost
valu
select
neonat
sir
definit
hospit
foal
method
retrospect
multicent
studi
n
includ
ill
neonat
foal
standard
physic
clinicopatholog
admiss
find
obtain
three
sir
definit
directli
compar
equin
sirsneo
base
vital
leukocyt
lactat
glucos
paramet
wong
sirsp
adapt
diagnost
criteria
pediatr
patient
goldstein
sirsdh
propos
standard
sir
diagnosi
foal
consensu
meet
binari
statist
test
logist
regress
analys
p
perform
estim
prognost
valu
sir
determin
util
neutrophil
band
neutrophil
total
leukocyt
assess
propos
diagnost
criteria
sir
result
total
foal
filli
survivor
includ
median
age
day
diagnos
sirsneo
sirsp
sirsdh
significantli
associ
nonsurviv
sirsdh
show
highest
mortal
risk
odd
ratio
p
assess
neutrophil
count
lieu
total
leukocyt
number
exclus
band
neutrophil
diagnost
criteria
sir
minim
reduc
likelihood
predict
mortal
diagnosi
sir
absenc
sirsdh
like
associ
surviv
predict
valu
conclus
data
support
absenc
sir
base
assess
leukocyt
bodi
temperatur
heart
respiratori
rate
may
identifi
foal
lower
fatal
risk
follow
critic
ill
applic
sirsdh
criteria
slightli
outperform
diagnost
method
test
buriko
silverstein
univers
pennsylvania
philadelphia
pa
usa
introduct
viscoelast
test
recent
gain
popular
veterinari
medicin
diagnosi
coagul
disord
due
technic
difficulti
sensit
equip
use
limit
novel
portabl
handheld
viscoelast
analyz
viscoelast
coagul
monitor
vcm
vet
design
fulfil
clinic
need
viscoelast
test
follow
venipunctur
whole
fresh
blood
directli
place
dispos
cassett
vcm
test
within
cassett
glass
capillari
plate
move
relat
blood
sampl
place
cassett
cover
lens
plate
initi
contact
activ
numer
valu
gener
includ
clot
time
ct
clot
format
time
cft
alpha
angl
clot
firm
x
minut
maxim
clot
function
mcf
object
object
studi
establish
refer
interv
vcm
healthi
canin
popul
assess
variabl
individu
vcm
devic
evalu
vcm
perform
use
thromboelastographi
teg
perform
without
tissu
factor
tf
activ
method
blood
healthi
adult
dog
collect
perform
jugular
venipunctur
immedi
upon
collect
blood
directli
ad
syring
dose
cassett
vcm
devic
perform
test
duplic
remain
blood
place
citrat
tube
rest
time
teg
test
perform
concurr
one
recalcifi
whole
blood
tf
dilut
result
canin
refer
interv
vcm
ct
second
cft
second
alpha
angl
degre
vcm
unit
unit
mcf
unit
coeffici
variat
vcm
devic
rang
ct
cft
teg
refer
interv
deriv
popul
similar
previous
report
refer
nativ
tf
activ
sampl
posit
correl
document
vcm
correspond
teg
paramet
conclus
vcm
feasibl
option
semiquantit
point
care
viscoelast
test
investig
devic
perform
dog
alter
coagul
necessari
ceccherini
g
cadringh
v
breghi
g
briganti
depart
veterinari
scienc
univers
pisa
piero
grado
itali
object
describ
techniqu
percutan
tracheostomi
use
portex
minitrach
ii
selding
kit
canin
cadaver
model
studi
design
ex
vivo
studi
anim
canin
cadav
n
method
percutan
tracheostomi
perform
use
portex
minitrach
ii
selding
kit
ii
design
rapid
peopl
kit
enabl
placement
cannula
mm
id
trachea
util
selding
techniqu
anim
differ
breed
weight
use
studi
time
need
percutan
punctur
introduct
minitrach
tube
record
complic
record
classifi
difficulti
locat
anatom
tracheal
marker
larg
neck
obes
guid
wire
kink
difficult
slide
cannula
guid
second
deeper
skin
incis
need
time
minut
number
complic
complet
procedur
consid
success
data
test
normal
dagostino
pearson
test
time
placement
compar
complic
encount
site
placement
use
pair
respect
p
consid
signific
result
placement
minitrach
success
dog
median
weight
dog
enrol
kg
kg
averag
age
year
time
requir
place
cannula
minut
site
placement
tracheal
ring
dog
tracheal
ring
complic
found
two
dog
main
complic
regist
number
follow
complic
number
one
dog
complic
number
overweight
dog
regist
signific
differ
found
time
need
site
placement
complic
p
conclus
percutan
tracheostomi
use
portex
minitrach
ii
selding
kit
feasibl
rel
easi
rapid
techniqu
investig
altern
tracheostomi
initi
stabil
dog
sever
respiratori
distress
emerg
set
warrant
doerfelt
r
imbach
e
grotheer
ms
clinic
small
anim
medicin
univers
munich
germani
introduct
critic
ill
dog
cat
often
hypotherm
effect
warm
improv
cardiovascular
respons
metabol
aim
studi
compar
efficaci
patient
warm
system
dog
cat
method
hypotherm
dog
cat
veterinari
univers
icu
prospect
includ
studi
patient
warm
randomli
perform
either
bair
hugger
hotbodi
system
temperatur
bair
hugger
set
hotbodi
interv
rectal
temperatur
monitor
everi
minut
achiev
patient
toler
warm
sixteen
anim
exclud
durat
warm
shorter
minut
result
analyz
normal
pearson
omnibu
normal
test
data
analyz
u
test
result
dog
cat
enrol
seven
patient
hypotherm
due
underli
diseas
due
anesthesia
perform
advanc
stare
temperatur
median
durat
warm
minut
minut
bair
hugger
minut
minut
hotbodi
p
end
temperatur
bair
hugger
hotbodi
p
temperatur
increas
minut
use
bair
hugger
use
hotbodi
system
p
patient
temperatur
increas
differ
time
point
warm
devic
temperatur
drop
stop
median
minut
minut
temperatur
increas
time
point
minut
minut
bair
hugger
stop
decreas
minut
minut
increas
minut
minut
use
hotbodi
system
p
p
warm
stop
due
reach
target
temperatur
patient
group
three
dog
euthan
toler
warm
reach
target
temperatur
conclus
warm
devic
effect
differ
patient
warm
median
temperatur
increas
minut
garcia
arc
gow
handel
ngoi
thoma
london
unit
kingdom
dick
school
veterinari
studi
edinburgh
unit
kingdom
introduct
red
blood
cell
distribut
width
rdw
measur
size
variabl
circul
red
blood
cell
increas
rdw
associ
outcom
peopl
specif
diseas
process
also
critic
ill
patient
limit
veterinari
studi
use
rdw
prognost
biomark
use
previous
evalu
critic
ill
dog
object
assess
correl
high
rdw
valu
outcomelength
hospit
critic
ill
dog
method
data
collect
retrospect
dog
admit
consecut
intens
care
unit
icu
veterinari
teach
hospit
decemb
april
patient
includ
complet
blood
cell
count
perform
within
first
hour
hospit
avail
biochemistri
paramet
use
calcul
applefast
score
patient
group
accord
diagnosi
subgroup
analysi
perform
surviv
discharg
length
stay
record
result
dog
admit
icu
studi
period
met
inclus
criteria
median
age
year
iqr
male
neuter
femal
neuter
patient
group
diagnost
categori
abdomin
hematolog
respiratori
neurolog
cardiovascular
integu
traumat
event
musculoskelet
other
overal
mortal
rate
median
length
hospit
stay
day
iqr
median
rdw
valu
iqr
refer
rang
applefast
score
calcul
patient
median
score
iqr
signific
correl
rdw
applefast
score
increas
rdw
associ
outcom
overal
p
outcom
individu
subgroup
analysi
associ
found
length
stay
high
rdw
valu
either
survivor
p
nonsurvivor
p
conclus
studi
rdw
found
accur
prognost
indic
critic
ill
dog
grossi
g
r
bergamini
pietra
fracassi
f
dondi
f
giunti
depart
veterinari
medic
scienc
univers
bologna
ozzano
dellemila
bo
itali
introduct
alter
lipid
profil
human
sepsi
specif
decreas
serum
concentr
associ
greater
diseas
sever
mortal
recent
measur
biomark
treatment
monitor
dog
leishmaniosi
howev
use
canin
sepsi
unknown
studi
aim
evalu
diagnost
prognost
role
serum
concentr
dog
sepsi
method
serum
sampl
collect
februari
octob
dog
sepsi
n
acut
hemorrhag
diarrhea
syndrom
ahd
n
healthi
control
n
retrospect
analyz
septic
dog
subgroup
accord
sepsi
origin
septic
periton
n
parvovir
enter
n
pyometra
n
miscellan
n
measur
use
immunoturbidimetr
method
previous
valid
dog
nonparametr
statist
use
comparison
data
report
median
rang
p
set
result
signific
differ
found
concentr
overal
popul
septic
dog
mgdl
ahd
mgdl
healthi
dog
mgdl
p
howev
signific
lower
concentr
document
dog
septic
periton
mgdl
compar
ahd
healthi
dog
dog
parvovir
enter
mgdl
healthi
control
p
septic
dog
signific
lower
concentr
detect
nonsurvivor
mgdl
n
compar
survivor
mgdl
n
p
accord
auroc
curv
analysi
mgdl
fair
accuraci
auc
correctli
predict
mortal
p
conclus
diagnost
potenti
select
diseas
caus
canin
sepsi
eg
septic
periton
parvovir
enter
warrant
moreov
seem
prognost
popul
septic
dog
find
promis
canin
sepsi
parallel
human
data
whether
decreas
concentr
reflect
greater
sepsi
sever
directli
contribut
immun
dysfunct
yet
determin
prospect
studi
need
confirm
prognost
signific
dog
sepsi
evalu
diagnost
perform
homogen
model
canin
sepsi
hopper
rezend
borcher
california
davi
ca
usa
state
univers
fort
collin
co
usa
introduct
current
cardiopulmonari
resuscit
cpr
guidelin
dog
recommend
ventil
cpr
cuf
orotrach
tube
possibl
ventil
tight
fit
face
mask
rescu
breath
consid
reason
option
guidelin
note
efficaci
altern
method
ventil
evalu
object
studi
compar
effect
manual
ventil
use
tight
fit
face
mask
rescu
breath
cuf
orotrach
tube
cpr
dog
method
research
dog
termin
teach
laboratori
random
ventil
orotrach
tube
n
tight
fit
face
mask
n
breath
n
ventil
n
cpr
orotrach
tube
face
mask
ventil
perform
use
mask
room
air
chest
compress
perform
experiment
procedur
cpr
intervent
provid
arteri
blood
gase
perform
prior
euthanasia
baselin
minut
minut
cpr
compar
time
point
group
result
differ
group
baselin
minut
group
significantli
higher
p
facemask
ventil
group
significantli
lower
p
compar
orotrach
tube
group
differ
group
compar
orotrach
tube
group
minut
gastric
distens
regurgit
face
mask
leak
note
face
mask
group
gastric
distent
regurgit
note
group
one
dog
breath
fail
gener
effect
breath
entir
period
cpr
conclus
studi
ventil
provid
better
oxygen
face
mask
ventil
although
supplement
oxygen
like
facemask
ventil
would
show
greater
efficaci
ventil
mayb
effect
rescu
breath
techniqu
dog
complic
note
face
mask
ventil
kelmer
e
aroch
segev
g
beeri
klainbart
koret
school
veterinari
medicin
hebrew
univers
jerusalem
rehovot
israel
introduct
vipera
palaestina
present
term
daboia
palaestina
common
venom
snake
israel
report
mortal
rate
rang
peopl
dog
envenom
palaestina
respect
object
peopl
envenom
palaestina
rabbit
inject
venom
serum
cholesterol
concentr
schol
invers
correl
sever
envenom
therefor
hypothes
dog
envenom
palaestina
schol
may
serv
marker
sever
outcom
method
data
retrospect
collect
medic
record
dog
diagnos
palaestina
envenom
schol
measur
present
result
studi
includ
dog
overal
mortal
rate
median
schol
significantli
p
lower
nonsurvivor
dog
mgdl
compar
survivor
dog
mgdl
mean
serum
albumin
concentr
significantli
p
lower
nonsurvivor
dog
gdl
compar
survivor
dog
gdl
receiv
oper
characterist
roc
analys
schol
salb
present
predictor
outcom
area
curv
auc
respect
optim
schol
cutoff
mgdl
correspond
sensit
specif
optim
salb
cutoff
gdl
correspond
sensit
specif
differ
mean
schol
dog
present
differ
mental
status
dog
normal
mentat
significantli
higher
schol
mgdl
compar
depress
obtund
semicoma
coma
mgdl
mgdl
mgdl
respect
p
schol
significantli
lower
dog
present
leukocytosi
hypoproteinaemia
thrombocytopenia
p
conclus
present
result
show
schol
present
good
marker
sever
envenom
moder
outcom
predictor
dog
envenom
palaestina
addit
presenc
hypocholesterolemia
may
aid
diagnosi
snake
envenom
dog
present
vagu
clinic
sign
futur
studi
need
evalu
whether
chang
schol
throughout
hospit
correl
clinic
improv
outcom
lang
boysen
stillion
bentley
atilla
veterinari
specialist
emerg
centr
calgari
canada
calgari
calgari
canada
veterinari
specialist
centr
calgari
canada
winner
best
oral
present
background
numer
anatom
site
may
facilit
placement
intraoss
cathet
tradit
tibia
site
choic
intraoss
cathet
placement
veterinari
medicin
howev
human
studi
site
humeru
shown
equival
flow
rate
eas
placement
may
import
consider
resuscit
hypovolem
patient
object
compar
intraoss
cathet
placement
difficulti
success
rate
flow
rate
four
differ
anatom
locat
canin
cadav
method
anim
care
committe
approv
owner
consent
obtain
prospect
studi
dog
present
euthanasia
recruit
heparin
iukg
intraven
administ
least
minut
prior
euthanasia
euthanasia
ezio
intraoss
cathet
place
ilial
wing
proxim
medial
tibia
proxim
later
humeru
distal
later
femur
one
side
anim
steril
salin
infus
locat
simultan
minut
first
via
graviti
follow
mm
hg
pressur
procedur
repeat
contralater
side
anim
analysi
varianc
perform
evalu
differ
anatom
site
p
consid
statist
signific
result
placement
success
ilial
wing
tibial
femor
humer
attempt
graviti
infus
rate
tibia
mlkgmin
statist
lower
humeru
mlkgh
femur
mlkgmin
pressur
infus
rate
tibia
mlkgmin
statist
lower
humeru
mlkgmin
femur
mlkgmin
statist
signific
differ
note
flow
rate
site
conclus
pressur
intraoss
flow
rate
higher
humeru
femur
compar
tibia
addit
humeru
femur
highest
success
placement
compar
tibia
ileum
suggest
humeru
femur
may
prefer
site
intraoss
cathet
placement
dog
rapid
infus
rate
desir
le
gal
thoma
humm
scienc
servic
royal
veterinari
colleg
hatfield
unit
kingdom
royal
dick
school
veterinari
studi
edinburgh
unit
kingdom
introduct
xenotransfus
canin
blood
cat
recogn
veterinari
techniqu
literatur
describ
outcom
lack
object
studi
threefold
first
review
describ
clinic
situat
xenotransfus
perform
second
describ
outcom
recipi
cat
third
assess
recipi
owner
retent
inform
regard
xenotransfus
method
cat
administ
xenotransfus
referr
hospit
januari
decemb
recruit
reason
transfus
blood
type
pcv
result
transfus
volum
transfus
reaction
pcv
posttransfus
surviv
discharg
record
owner
cat
surviv
discharg
question
implic
xenotransfus
mean
standard
deviat
calcul
normal
distribut
data
median
interquartil
rang
calcul
nonparametr
data
result
cat
enrol
common
reason
transfus
surgic
complic
imha
neoplasia
cat
blood
type
b
ab
two
cat
blood
type
median
pcv
prior
transfus
iqr
major
minor
incompat
case
case
respect
median
volum
transfus
mlkg
iqr
four
cat
febril
nonhemolyt
transfus
reaction
mean
pcv
hour
posttransfus
hemolyt
serum
note
cat
median
hour
iqr
icteru
icter
serum
cat
median
hour
iqr
surviv
discharg
eight
cat
receiv
felin
blood
transfus
median
day
iqr
postxenotransfus
includ
cat
evid
either
hemolysi
icteru
eleven
cat
aliv
januari
mean
day
postxenotransfus
owner
rememb
cat
receiv
xenotransfus
rememb
cat
could
receiv
repeat
xenotransfus
conclus
xenotransfus
canin
blood
cat
possibl
hemolysi
expect
day
posttransfus
repeat
transfus
felin
blood
often
requir
mayr
bauer
reichart
issl
ying
brenner
abicht
maximilian
univers
munich
germani
klinikum
rosenheim
rosenheim
germani
munich
germani
introduct
postop
manag
essenti
outcom
cardiac
transplant
preclin
model
futur
xenotransplant
peopl
inform
use
baboon
complex
experi
scarc
claim
specif
manag
cardiac
posttranspl
condit
manag
reach
beyond
usual
treatment
laboratori
anim
transfer
medic
treatment
human
patient
possibl
neither
materi
ten
orthotop
heart
transplant
perform
use
cardiopulmonari
bypass
two
day
prior
transplant
anim
receiv
multilumen
central
venou
cathet
continu
intraven
treatment
daili
laboratori
measur
organ
function
transplant
telemetr
devic
implant
continu
transmit
epicardi
electrocardiogram
system
blood
pressur
echocardiographi
serv
import
tool
comprehens
evalu
graft
function
result
baboon
male
papio
anubi
median
rang
age
bodi
weight
year
kg
respect
continu
telemetr
monitor
possibl
anim
four
anim
could
wean
respir
due
periop
xenograft
dysfunct
arrhythmia
observ
anim
ventricular
extrasystol
treat
administr
amiodaron
magnesium
electrolyt
close
monitor
substitut
two
first
postop
week
three
anim
need
blood
transfus
postop
period
reduc
serum
albumin
concentr
observ
two
anim
human
albumin
transfus
perform
echocardiograph
evalu
perform
regular
basi
least
twice
week
advers
event
combin
sedat
blood
pressur
stabl
procedur
three
case
catecholamin
support
necessari
echocardiograph
evalu
reveal
diastol
failur
day
respect
xenotransplant
conclus
preclin
cardiac
xenotransplant
intens
postop
monitor
care
essenti
outcom
experi
experi
postop
intens
care
treatment
could
establish
lead
consist
surviv
orthotop
heart
transplant
sigrist
ne
jud
schefer
r
muri
b
vetsuiss
faculti
univers
zurich
switzerland
introduct
acut
traumat
coagulopathi
atc
preval
peopl
associ
mortal
singl
studi
report
atc
cat
object
determin
preval
atc
acut
traumat
cat
method
cat
present
acut
hour
trauma
march
decemb
prospect
enrol
rotat
thromboelastometri
lactat
anim
trauma
triag
att
score
determin
present
atc
defin
hypocoagabul
rotem
paramet
prolong
extem
intem
clot
time
ct
clot
format
time
cft
decreas
maximum
clot
firm
mcf
increas
maximum
lysi
ml
result
cat
analyz
median
time
trauma
present
minut
rang
minut
two
cat
actual
trauma
time
known
estim
hour
base
clinic
sign
median
att
score
rang
median
lactat
concentr
rang
mmoll
atc
demonstr
cat
one
cat
atc
show
hyperfibrinolysi
five
cat
act
show
ct
prolong
presenc
atc
associ
att
score
p
lactat
p
less
cat
vs
atc
discharg
hospit
howev
statist
signific
p
discuss
studi
identifi
atc
cat
acut
trauma
higher
preval
atc
found
cat
may
associ
earlier
evalu
trauma
associ
surviv
trauma
sever
hypoperfus
requir
futur
larger
studi
conclus
atc
seem
preval
traumat
cat
previous
thought
consid
cat
acut
trauma
starybrat
elli
rozanski
humm
clinic
scienc
servic
royal
veterinari
colleg
hatfield
unit
kingdom
veterinari
medicin
univers
california
davi
ca
usa
school
veterinari
medicin
tuft
univers
north
grafton
usa
introduct
canin
tetanu
rare
neuromuscular
disord
caus
neurotoxin
produc
clostridium
tetani
diagnosi
diseas
base
patient
characterist
clinic
sign
small
number
studi
investig
tetanu
human
patient
note
season
variabl
incid
postul
due
variat
weather
season
canin
tetanu
investig
object
evalu
season
diagnosi
canin
tetanu
unit
kingdom
uk
unit
state
america
usa
method
medic
record
three
referr
hospit
one
uk
one
northeast
coast
usa
one
west
coast
usa
review
dog
diagnos
tetanu
diplom
either
emerg
critic
care
neurolog
intern
medicin
januari
june
includ
studi
local
gener
tetanu
case
includ
test
use
assess
signific
differ
distribut
tetanu
case
month
well
season
year
consid
signific
result
eight
case
northeast
coast
referr
hospit
case
west
coast
referr
hospit
case
uk
referr
hospit
includ
local
tetanu
document
present
dog
admit
veterinari
hospit
respect
season
note
either
usa
referr
hospit
monthli
season
diagnosi
tetanu
confirm
unit
kingdom
referr
hospit
p
valu
highest
number
case
record
februari
incid
tetanu
significantli
higher
winter
month
compar
summer
p
valu
autumn
p
valu
conclus
incid
canin
tetanu
unit
kingdom
referr
hospit
show
season
variat
higher
number
case
note
winter
month
especi
februari
seen
usa
referr
hospit
may
due
type
ii
statist
error
due
differ
weather
pattern
dupanloup
gillet
b
cambournac
c
vetagro
sup
campu
de
lyon
marci
letoil
franc
introduct
sonograph
measur
caudal
vena
cava
aorta
cvc
ao
ratio
previous
suggest
use
tool
emerg
critic
care
set
bedsid
serial
assess
intravascular
volum
statu
dog
howev
refer
interv
ri
establish
dog
object
determin
ri
cvcao
ratio
nonsed
healthi
dog
use
sonograph
assess
volemia
sav
protocol
evalu
interoper
variabl
ao
cvc
cvc
ao
ratio
measur
determin
sonograph
ao
cvc
cvc
ao
ratio
measur
correl
systol
blood
pressur
sbp
heart
rate
hr
method
prospect
studi
conduct
nonsed
healthi
dog
dog
posit
right
later
recumb
sbp
measur
three
time
consecut
use
doppler
system
left
kidney
identifi
view
abdomin
fast
techniqu
use
ultrasound
convex
transduc
cvc
ao
cvc
ao
ratio
measur
perform
twice
two
differ
oper
transvers
view
cvc
ao
ri
defin
percentil
interoper
variabl
assess
method
simpl
linear
correl
base
spearman
coeffici
determin
perform
sonograph
measur
sbp
hr
result
twenti
healthi
dog
includ
mean
age
year
mean
bodyweight
kg
ri
defin
cm
ao
cm
cvc
cvc
ao
ratio
interoper
variabl
within
limit
agreement
vast
major
measur
signific
correl
found
sonograph
measur
sbp
hr
conclus
low
interoper
variabl
sonograph
ao
cvc
cvc
ao
measur
confirm
reliabl
oper
independ
use
sav
protocol
cvc
ao
ratio
may
suggest
hypovolem
state
wherea
cvc
ao
ratio
may
suggest
hypervolem
state
dog
result
confirm
hypervolem
dog
buckley
gj
eid
sanchez
lc
allen
ls
zimmel
dn
univers
florida
colleg
veterinari
medicin
gainesvil
fl
usa
introduct
problem
misinterpret
written
order
identifi
error
includ
administr
whole
tablet
fraction
tablet
order
confus
aris
use
total
milligram
drug
versu
milligram
per
kilogram
bodyweight
vari
format
use
clinician
hypothes
contribut
error
exampl
order
commonli
misinterpret
includ
aspirin
tablet
daili
methadon
mgkg
intraven
everi
hour
object
reduc
error
associ
misinterpret
written
order
method
standard
format
written
order
introduc
follow
drug
name
total
mg
dose
rout
administr
frequenc
idinc
use
record
medic
error
search
identifi
total
error
report
year
polici
chang
well
total
medic
error
medic
error
result
misinterpret
clinician
order
use
compar
categor
variabl
implement
result
total
report
per
patient
visit
compar
per
patient
visit
reflect
increas
overal
report
period
caseload
increas
medic
error
respect
error
result
error
dose
administ
patient
result
harm
patient
error
result
error
dosag
result
patient
harm
significantli
differ
p
dose
error
attribut
misinterpret
written
order
fell
p
case
protocol
follow
two
instanc
protocol
follow
misinterpret
order
occur
conclus
implement
standard
order
write
result
signific
reduct
dose
error
relat
misinterpret
error
result
misinterpret
order
seen
postprotocol
associ
failur
follow
standard
format
vigil
address
complianc
may
result
improv
cole
lp
humm
k
depart
clinic
scienc
servic
royal
veterinari
colleg
hatfield
unit
kingdom
introduct
object
studi
describ
clinic
use
outcom
autolog
transfus
cat
method
retrospect
descript
studi
perform
medic
record
singl
referr
centr
search
cat
receiv
autotransfus
part
case
manag
underli
diseas
process
injuri
autotransfus
techniqu
transfus
volum
time
period
transfus
given
pcv
posttransfus
percentag
rise
pcv
use
blood
product
complic
procedur
record
surviv
discharg
inform
also
document
result
juli
juli
total
autotransfus
perform
cat
median
weight
cat
undergo
autotransfus
kg
rang
kg
patient
diagnos
haemoperitoneum
four
cat
diagnos
abdomin
neoplasia
postop
haemorrhag
traumat
haemoperitoneum
hospit
cat
receiv
multipl
autotransfus
cat
receiv
autotransfus
preoper
stabil
cat
receiv
autotransfus
postop
one
cat
receiv
repeat
autotransfus
later
hospit
admiss
date
blood
collect
use
ga
butterfli
cathet
ml
syring
collect
ga
needl
tap
ml
syring
collect
directli
syring
open
abdomen
time
surgeri
collect
median
volum
ml
rang
ml
collect
administ
equival
median
dose
mlkg
rang
mlkg
blood
given
median
hour
hour
four
cat
given
anoth
blood
product
alongsid
autotransfus
median
percentag
pcv
increas
postautotransfus
rang
anticoagul
use
autotransfus
clinic
relev
advers
effect
report
five
patient
surviv
discharg
caus
death
patient
euthanasia
due
underl
condit
continu
haemorrhag
conclus
autolog
transfus
appear
safe
effect
techniqu
stabil
cat
haemoperitoneum
techniqu
allow
rapid
cheap
provis
blood
avoid
need
allogen
blood
donor
daza
fragio
c
portero
fermin
pelaez
p
garcia
r
wuhrmann
b
hospit
veterinario
complutens
madrid
spain
introduct
intraven
lipid
therapi
ivlt
administr
infus
intraven
lipid
emuls
ile
short
period
time
amelior
clinic
syndrom
caus
lypophyl
drug
overdos
toxin
background
potenti
advers
effect
ivlt
includ
microvascular
fat
embol
pancreat
object
object
studi
monitor
plasmat
level
cholesterol
ch
triglycerid
tg
ivlt
hypothes
valu
ivlt
would
differ
method
patient
diagnos
nsaid
intox
base
histori
clinicallaboratori
sign
addit
decontamin
support
measur
ile
lipofundina
administ
initi
bolu
mlkg
minut
follow
cri
mlkgmin
hour
plasma
ch
tg
measur
prior
ivlt
hour
hour
posttherapi
given
nonparametr
distribut
data
friedmann
test
use
analyz
result
signific
set
p
result
two
cat
f
european
shorthair
dog
f
variou
breed
intox
meloxicam
n
ibuprofen
n
carprofen
n
diclofenac
n
enrol
ch
valu
significantli
differ
p
valu
express
median
interquartil
rang
mgdl
mgdl
mgdl
signific
differ
observ
tg
mgdl
mgdl
p
mgdl
n
patient
tg
valu
upper
limit
refer
rang
discuss
result
indic
patient
receiv
ivlt
measur
plasma
tg
level
hour
may
use
evalu
potenti
risk
give
second
dose
ile
exampl
anim
intox
substanc
enterohepat
circul
ch
level
monitor
use
sinc
chang
significantli
treatment
preliminari
result
confirm
larger
patient
sampl
conclus
patient
intox
substanc
enterohepat
circul
determin
plasma
triglycerid
hour
start
ivlt
may
help
decid
safe
administ
second
dose
ile
elia
n
lewi
vet
referr
glasgow
glasgow
unit
kingdom
introduct
use
plasma
transfus
continu
grow
veterinari
medicin
plasma
transfus
reaction
tr
poorli
character
compar
reaction
secondari
administr
pack
red
blood
cell
object
describ
popul
receiv
plasma
product
pp
period
report
incid
tr
identifi
whether
higher
plasma
administ
method
search
computer
record
perform
identifi
patient
receiv
pp
product
includ
frozen
plasma
fp
fresh
frozen
plasma
ffp
cryoprecipit
cryo
patient
exclud
record
incomplet
blood
type
plasma
record
result
total
case
review
includ
studi
total
pp
transfus
analyz
given
blood
type
patient
total
tr
note
six
tr
identifi
follow
ffp
transfus
administr
fp
none
follow
administr
cryo
tr
mild
one
requir
discontinu
transfus
tr
identifi
pp
administr
greater
proport
transfus
although
differ
statist
signific
patient
receiv
unit
pp
receiv
unit
three
tr
occur
patient
receiv
unit
patient
receiv
unit
p
total
tr
occur
patient
also
receiv
prbc
transfus
p
discuss
overal
incid
tr
low
invari
mild
natur
appear
evid
administ
pp
affect
rate
tr
trend
show
pp
patient
receiv
like
tr
conclus
administr
canin
pp
safe
procedur
carri
low
risk
transfus
reaction
pp
appear
unneccesari
evid
strong
trend
indic
increas
risk
tr
increas
number
pp
administ
gori
e
pierini
lippi
ceccherini
g
luba
g
marchetti
v
depart
veterinari
scienc
univers
pisa
san
piero
grado
pisa
itali
introduct
neutrophil
lymphocyt
ratio
nlr
propos
readili
access
independ
predictor
paramet
poor
surviv
human
patient
tumor
cardiovascular
diseas
critic
ill
far
know
nlr
evalu
oncolog
veterinari
patient
object
evalu
nlr
dog
system
inflammatori
respons
syndrom
sir
associ
sever
ill
outcom
sepsi
blr
band
ratio
blnr
ratio
evalu
well
method
data
retrospect
collect
enrol
anim
subsequ
divid
group
sir
healthi
chronic
diseas
control
group
sir
grade
obtain
base
mani
criteria
fulfil
applefast
score
appli
sir
group
surviv
rate
assess
day
admiss
dog
cytolog
posit
cultur
activ
bacteri
infect
record
septic
test
dunn
multipl
comparison
test
use
compar
group
use
statist
softwar
result
sir
group
dog
die
studi
period
applefast
score
p
sir
grade
p
associ
poor
outcom
nlr
higher
sir
group
compar
control
group
p
p
respect
associ
outcom
nlr
statist
differ
sir
grade
group
applefast
score
group
nlr
lower
septic
dog
nonsept
group
p
dog
sir
grade
show
higher
blr
dog
sir
grade
p
associ
blr
blnr
outcom
sepsi
applefast
group
found
conclus
result
demonstr
util
nlr
evalu
dog
sir
higher
septic
dog
lower
prospect
studi
investig
role
blr
blnr
canin
sir
warrant
hoareau
gl
grayson
jk
clinic
investig
facil
fairfield
ct
usa
introduct
pig
commonli
use
translat
research
accur
assess
coagul
essenti
sought
establish
porcin
rotem
normal
valu
pig
follow
american
societi
veterinari
clinic
patholog
refer
interv
guidelin
method
healthi
yorkshir
cross
pig
male
femal
anesthet
intramuscular
inject
tiletamin
zolazepam
use
ga
needl
attach
vacutain
blood
acquir
cranial
vena
cava
tube
fill
follow
order
evacu
clot
tube
edta
tube
heparin
tube
citrat
tube
citrat
tube
randomli
assign
minut
without
constant
agit
rocker
follow
intem
extem
paramet
report
accord
manufactur
recommend
ct
cft
alpha
mcf
ml
refer
interv
report
percentil
popul
result
effect
sex
sampl
order
agit
rotem
result
analyz
via
linear
regress
result
sex
sampl
order
agit
influenc
rotem
paramet
pool
refer
interv
establish
rotem
paramet
combin
data
male
femal
anim
nonagit
tube
conclus
first
studi
establish
rotem
refer
interv
larg
number
male
femal
adult
pig
also
provid
detail
preanalyt
sampl
process
result
provid
valuabl
inform
research
util
porcin
model
jandrey
ke
rosati
burg
jw
kent
ms
univers
california
davi
ca
usa
introduct
viscoelast
test
uncommonli
avail
provid
inform
overal
hemostasi
novel
viscoelast
devic
portabl
coagul
monitor
pcm
intend
larger
veterinari
audienc
sinc
simpl
use
portabl
thromboelastographi
teg
rotat
thromboelastometri
rotem
first
studi
evalu
pcm
popul
healthi
cat
background
clinic
applic
viscoelast
test
limit
high
cost
technic
knowledg
skill
requir
access
object
aim
studi
establish
pcm
refer
interv
popul
healthi
cat
evalu
data
correl
teg
method
healthi
domest
shorthair
cat
n
assess
studi
blood
direct
venipunctur
immedi
analyz
pcm
anticoagul
blood
sodium
citrat
teg
edta
cbc
analyz
within
hour
statist
analysi
complet
use
commerci
avail
softwar
stata
microsoft
excel
refer
valu
advisor
result
blood
obtain
cat
femal
male
median
year
rang
cbc
paramet
within
normal
refer
interv
measur
refer
interv
rang
median
mean
standard
deviat
normal
distribut
pcm
measur
clot
time
ct
second
clot
format
time
cft
second
alpha
angl
aa
degre
maximum
clot
firm
mcf
pcm
unit
lysi
index
lysi
minut
ct
teg
measur
respect
rang
median
reaction
time
r
minut
kinet
k
minut
alpha
angl
aa
degre
maximum
amplitud
millimet
lysi
discuss
data
healthi
cat
suggest
pcm
measur
directli
compar
teg
measur
two
devic
assess
viscoelast
properti
blood
differ
data
appear
directli
compar
howev
pcm
analysi
may
still
use
evalu
hemostasi
healthi
cat
studi
requir
ensur
applic
pcm
clinic
set
conclus
novel
viscoelast
coagulomet
use
analysi
healthi
cat
correl
thromboelastographi
langhorn
r
poulsen
mk
heidemann
pl
bochsen
l
kristensen
nielsen
ln
depart
veterinari
clinic
scienc
univers
copenhagen
copenhagen
denmark
winner
best
origin
studi
poster
introduct
hyperfibrinolysi
possibl
caus
bleed
canin
cancer
patient
howev
diagnosi
therapi
remain
challeng
standard
thromboelastographi
may
robust
detect
canin
hyperfibrinolysi
studi
evalu
tissu
plasminogen
thromboelastographi
detect
hyperfibrinolysi
aim
establish
concentr
antifibrinolyt
agent
tranexam
acid
txa
need
normal
fibrinolyt
potenti
vitro
method
canin
patient
sarcoma
normocoagul
thromboelastographi
includ
along
healthi
control
group
dog
whole
blood
four
ad
txa
perform
lysi
paramet
lysi
minut
follow
maxim
amplitud
clot
lysi
index
minut
follow
maximum
rate
lysi
mrl
total
lysi
l
investig
vitro
txa
concentr
need
inhibit
fibrinolyt
potenti
calcul
result
nine
patient
cancer
hemangiosarcoma
osteosarcoma
clinic
bleed
healthi
dog
includ
signific
hyperfibrinolysi
p
p
p
l
p
detect
sarcoma
patient
txa
normal
healthi
dog
patient
sarcoma
conclus
signific
hyperfibrinolysi
detect
group
canin
patient
sarcoma
vitro
concentr
txa
necessari
normal
markedli
increas
group
compar
healthi
dog
sigrist
ne
muri
b
herrero
jud
schefer
r
vetsuiss
faculti
univers
zurich
switzerland
introduct
acut
traumat
coagulopathi
atc
describ
human
trauma
patient
hyperfibrinolysi
common
atc
identifi
dog
preval
dog
may
object
prospect
describ
chang
rotem
paramet
time
determin
preval
atc
hyperfibrinolysi
dog
acut
trauma
method
dog
present
acut
hour
trauma
includ
paramet
thrombocyt
count
anim
trauma
triag
att
score
lactat
evalu
within
hour
trauma
hour
present
rotem
trace
defin
hypercoagul
follow
paramet
refer
interv
clot
time
clot
format
time
maximum
clot
firm
maximum
lysi
maximum
clot
elast
atc
defin
hypocoagul
rotem
trace
result
dog
includ
present
analyz
hour
respect
present
dog
present
atc
dog
hypercoagul
dog
thrombocytopen
dog
show
hyperfibrinolysi
hour
dog
show
atc
hour
none
dog
show
atc
hypercoagul
thrombocytopen
show
hyperfibrinolysi
preliminari
data
set
atc
associ
trauma
sever
hyperlactatemia
surviv
discuss
studi
found
higher
preval
atc
dog
trauma
previous
report
describ
peopl
hypocoagul
phase
hyperfibrinolysi
shortli
trauma
follow
hypercoagul
phase
stabil
associ
trauma
sever
shock
remain
investig
larger
studi
conclus
chang
coagul
paramet
trauma
dog
chang
time
earli
trauma
atc
includ
hyperfibrinolysi
present
hypercoagul
predomin
hour
trauma
soar
ferreira
cardoso
correia
gopegui
mato
blood
bank
porto
portug
anim
medicin
surgeri
veterinari
faculti
barcelona
spain
biomed
scienc
abel
sala
porto
portug
introduct
pack
cell
volum
bacteri
contamin
hemolysi
storag
import
prbc
qualiti
paramet
singl
report
address
subject
howev
significantli
lower
number
unit
test
import
limit
object
studi
aim
evalu
qualiti
control
program
store
canin
prbc
need
qualiti
control
analysi
administr
unit
week
accord
criteria
establish
council
europ
guidelin
human
blood
blank
method
accord
qualiti
control
protocol
privat
blood
bank
unit
produc
total
randomli
evalu
hour
process
bacteri
cultur
determin
use
aerob
cultur
bottl
specif
growth
medium
along
hematocrit
hemolysi
percentag
order
ensur
qualiti
store
unit
yet
use
first
week
day
storag
day
total
prbc
unit
respect
test
result
two
blood
cultur
test
posit
bacteri
growth
contamin
staphylococcu
sp
isol
mean
hematocrit
mean
hemolysi
increas
addit
prbc
unit
exceed
hemolysi
respect
discussionconclus
accord
council
europ
guidelin
human
blood
bank
recommend
maximum
hemolysi
present
store
blood
unit
low
number
posit
cultur
valid
steril
canin
collect
prbc
product
confirm
safeti
use
transfusion
medicin
low
valu
hemolysi
hematocrit
found
process
also
valid
process
protocol
use
produc
canin
compon
prbc
unit
store
day
test
hemolysi
use
sinc
unit
exceed
limit
hemolysi
dozeman
et
pritti
je
fischetti
aj
anim
medic
center
new
york
ny
introduct
trauma
common
present
complaint
emerg
room
er
rapid
assess
injuri
necessari
imag
trauma
patient
import
guid
intervent
delay
resuscit
effort
use
whole
bodi
comput
tomographi
wbct
becom
common
practic
within
human
emerg
depart
less
common
within
veterinari
medicin
like
due
cost
access
concern
gener
anesthesia
critic
patient
vetmous
trap
develop
allow
ct
perform
veterinari
patient
minim
sedat
manipul
advantag
may
circumv
concern
polytrauma
patient
excess
sedat
anesthesia
allow
advanc
imag
perform
reduc
stress
patient
object
determin
safeti
feasibl
util
vetmous
trap
wbct
polytrauma
patient
method
prospect
observ
studi
high
volum
privat
practic
cat
dog
weigh
kg
present
er
follow
polytrauma
elig
patient
given
analgesia
sedat
per
propos
protocol
prior
placement
vetmous
trap
wbct
perform
result
total
patient
met
inclus
criteria
dog
cat
patient
present
blunt
trauma
also
evid
penetr
wound
five
patient
met
inclus
criteria
wbct
base
neurolog
evalu
five
nonambulatori
suspicion
orthoped
injuri
met
addit
criteria
wbct
common
area
injuri
patient
popul
head
lung
pelvi
four
patient
evid
cavitari
effus
seen
fast
scan
patient
advers
event
ct
conclus
studi
demonstr
success
wbct
imag
sedat
small
anim
polytrauma
patient
vetmous
trap
letendr
gogg
dmv
quebec
canada
univers
colleg
veterinari
medicin
ithaca
ny
introduct
trauma
common
dog
caus
signific
morbid
mortal
remain
challeng
predict
prognosi
dog
traumat
injuri
object
investig
plasma
dna
cfdna
nucleosom
concentr
prognost
biomark
canin
trauma
method
dog
trauma
consecut
enrol
follow
hospit
discharg
dog
elig
enrol
anim
trauma
triag
att
score
present
dog
kg
coagulopathi
exclud
healthi
control
dog
also
enrol
ill
injuri
sever
score
calcul
plasma
cfdna
measur
triplic
use
benchtop
fluoromet
plasma
nucleosom
concentr
determin
duplic
elisa
u
test
use
compar
biomark
concentr
group
survivor
nonsurvivor
associ
biomark
evalu
use
spearman
correl
coeffici
alpha
set
result
concentr
cfdna
nucleosom
significantli
higher
injur
dog
compar
control
p
nucleosom
cfdna
concentr
posit
correl
r
p
concentr
cfdna
nucleosom
correl
shock
index
r
p
r
p
respect
nucleosom
correl
att
r
p
appl
score
r
p
median
nucleosom
cfdna
concentr
significantli
higher
nonsurvivor
survivor
p
among
ill
sever
score
appl
discrimin
surviv
auroc
p
conclus
moder
sever
injur
dog
high
nucleosom
concentr
associ
nonsurviv
gogg
letendr
cornel
univers
colleg
veterinari
medicin
ithaca
ny
dmv
quebec
canada
introduct
pathophysiolog
respons
trauma
complex
state
innat
immun
system
follow
injuri
poorli
understood
dog
object
quantifi
plasma
cytokin
concentr
dog
trauma
evalu
potenti
prognost
marker
method
dog
anim
trauma
triag
att
score
present
consecut
enrol
follow
hospit
discharg
dog
kg
coagulopathi
exclud
healthi
control
dog
also
enrol
ill
injuri
sever
score
calcul
plasma
group
concentr
measur
elisa
concentr
cytokin
measur
use
multiplex
magnet
bead
assay
elisa
biomark
measur
duplic
u
test
use
compar
biomark
concentr
group
survivor
nonsurvivor
associ
biomark
evalu
use
spearman
correl
coeffici
independ
outcom
predictor
identifi
use
multivari
logist
regress
alpha
set
result
plasma
concentr
motif
keratinocyt
chemokin
significantli
greater
injur
dog
versu
control
p
univari
analys
significantli
greater
nonsurvivor
compar
survivor
ngml
versu
ngml
p
none
cytokin
associ
surviv
independ
ill
sever
measur
appl
score
howev
conclus
follow
moder
sever
injuri
dog
significantli
increas
concentr
inflammatori
cytokin
none
cytokin
prognost
howev
mathi
jc
acciacca
r
colorado
state
univers
veterinari
teach
hospit
fort
collin
co
usa
introduct
viscoelast
test
provid
inform
regard
hypocoagu
hyperfibrinolyt
tendenc
polytrauma
bedsid
method
requir
less
skill
expens
could
revolution
clinic
util
methodolog
object
evalu
novel
bedsid
viscoelast
coagul
devic
resuscit
dog
suffer
vehicular
trauma
method
pair
whole
blood
sampl
obtain
follow
vehicular
trauma
postresuscit
viscoelast
analysi
viscoelast
variabl
report
clot
time
ct
second
clot
format
time
cft
alpha
angl
x
amplitud
minut
minut
maximum
clot
firm
mcf
lysi
index
minut
result
preresuscit
ct
cft
angl
valu
within
normal
limit
mean
mean
mean
postresuscit
ct
valu
prolong
mean
angl
valu
normal
mean
mean
mean
smaller
alpha
angl
valu
note
postresuscit
mean
mean
mean
mean
mean
mean
conclus
trend
toward
hypocoagu
seen
follow
resuscit
hospit
trend
may
due
combin
acut
traumat
coagulopathi
loss
hemostat
factor
well
iatrogen
ie
hemodilut
studi
necessari
evalu
util
novel
viscoelast
devic
veterinari
patient
